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The use of skin-lightening products is a common practice, particularly in African 
countries.  The reasons for this practice may be of aesthetic, medical, cultural or socio-
economic origin.  Skin-lightening creams may contain several active ingredients which 
can be absorbed through the skin and cause side effects, especially after prolonged 
application.  The most common ingredients include hydroquinone and its derivatives, 
resorcinol, topical steroids of various potencies, and mercury-containing compounds.  
Exogenous ochronosis, postinflammatory hyperpigmentation, acne, striae, fish odour 
syndrome, and allergic dermatitis are the most reported dermatologic complications 
associated with lightening ingredients. 
 
In this work, some commonly used skin-lightening creams available in some of South 
Africa’s stores were investigated.  The objective was to identify and quantify the 
organic active ingredients and heavy metals in these creams. 
 
Forty-nine samples of skin-lightening creams were analysed to determine the levels of 
heavy metals (Cd, Co, Cr, Cu, Zn, Fe, Pb, Ni, As) and mercury.  These elements were 
extracted from the sample matrices by using acid-assisted microwave digestion and the 
extracts were analysed by ICP-OES and CV-AAS, respectively.  Among the 10 studied 
metals, only Cu and Fe were detected in all sample creams, whereas As, Cd, Co, and Ni 
were not detected in any of the cream samples.  Cr and Pb were detected in three 
samples while Zn and Hg were found at relatively high levels in a few samples.  The 
mean concentrations of detected metals ranged from 0.19 to 8.93 μg g-1 for Cu, 0.55 to 
25007 μg g-1 for Fe, 1.73 to 12.56 μg g-1 for Cr, 2.98 to 15.72 μg g-1 for Pb, 79.97 to 
12470 μg g-1 for Zn, and 2.48 to51.19 μg g-1 for Hg. 
 
A high performance liquid chromatography (HPLC) method was developed for the 
determination of the organic active ingredients in nineteen creams samples.  A UV 
spectrophotometer was employed to characterise the active ingredients within each 




preparation and the composition of the mobile phase for separation of the lightening 
agents have been investigated.  Methanol was found to be a suitable extraction solvent.  
By using a C18 column (100mm×4.6mm) and an isocratic elution performed at 289 nm, 
270 nm, and 240 nm, with a mobile phase (methanol: water, 55:45; v/v) pumped at 0.8 
mL min
-1
 , ingredients such as hydroquinone (HQ), arbutin (ARB), niacinamide (NA), 
phenol (PO), kojic acid (KA), hydrocortisone valerate (HCV), and clobetasol propionate 
(CP) were identified in twelve products. 
 
The quantitative results showed that the mean percentage concentrations of NA ranged 
from 0.035 to 1.170%, PO varied from 0.0025 to 0.920%, BQ varied from 0.008 to 
0.036% and ARB varied from 0.030 to 0.063% (m/m).  Furthermore, concentrations of 
0.94%, 0.055% and 0.0031% (m/m) were found for HQ, CP and HCV, respectively.  
Levels of KA are not reported for the present study because of tailing in the HPLC. 
Validation of the method was assessed by intra-day and inter-day reproducibility of 
standard, the linearity, detection limit, and recovery test.  The linear correlation 
coefficient has been found to be greater than about 0.995, the acceptable recovery 
values range from 87.4 to 105.04 %, the comparable precisions for intra-day (R.S.D 
between 0.038 and 1.86%) and inter-day (R.S.D between 0.60 and 2.83%) variability 
demonstrate that the method was suitable for the analysis of skin-lightening creams.   
 
It is clear from the present investigation that toxic compounds are being used as active 
ingredients or for other purposes in some skin-lightening creams.  This is of concern 
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INTRODUCTION AND LITERATURE 
REVIEW 
 
Pigmentation of the skin is directly or indirectly regulated by different physiological 
factors including melanin.
1,2
  Melanin is the major dark pigment found in skin, hair, and 





Studies have shown that the mean protective factor (PF) for ultraviolet light and ultravi-
olet light B (UVB, 280-320 nm) radiation of black epidermis is significantly higher than 
that of white epidermis.
5,7
  About three to four times more ultraviolet A (UVA, 320-
400nm) radiation reaches the upper dermis of whites than that of blacks.
7,9
  Black-
skinned people are less vulnerable to photoaging than white-skinned people.
9
  Since the 
amount and type of synthesised melanin influences the skin  complexion, either exces-
sive melanin production or deficient melanin production can cause pigmentary disor-
ders.
2
   
 
Hyperpigmentation and hypopigmentation are pigmentary disorders that are extremely 
common in blacks, Hispanics, and Asian.
11
  Moreover, acne vulgaris, eczema, contact 
dermatitis, fungal infections and other common dermatologic conditions are also unfa-
vourable aesthetic skin problems that affect everybody.
12
  In addition, a light and flaw-
less skin complexion is considered as a major contributor of human beauty, attractive-
ness and welfare.
13
  Consequently, various cosmetics and therapeutic treatments aimed 
at modulating melanogenesis have been used in order to control unwanted skin pigmen-
tation. 
 
Skin-lightening refers to the application of chemical agents in order to lighten the com-




skin-lightening has become a universal phenomenon socially practiced by both women 
and men.  For example, in African communities, light-brown skin type has been pre-
ferred since the colonial era.
13,14
  Many surveys
15-17
 agree that this practice originated 
from Africa's colonial and slave history where darker skin reflected dirty, unfair and 
wicked persons while light or white skin was associated with higher status, privileges, 
beauty and more intelligence.
14,18
  Certainly, this segregation affected dark-skinned 
people and caused them to believe that they are inferior and less beautiful.  Thus, it is 
understandable that some bleached their skin to try to attain the status associated with 
all manner of social and economic success.  Hence, the cosmetic use of skin-lightening 
products became an increasingly popular practice as early as the 1930s and is currently 
widespread.
12
   
 
Since the misconceived belief that darker skin is less beautiful is reflected in the prac-
tice of skin bleaching, it has led the cosmetic industry to manufacture various products 
that are designed to help dark-skinned people look lighter.  These products often come 
in a variety of preparations including creams, lotions, gels, soaps, powder and pills.  
Hydroquinone, retinoids, resorcinol, mercury, and corticosteroids are the main active 




Formulations of hydroquinone (4%), topical steroids and other skin-lightening agents 
such as tretinoin (0.1%), azelaic acid (20%) and kojic acid, are dermatologically used to 
treat acne and other pigmentary disorders such as postinflammatory hyperpigmentation 
and hypopigmentation, vitiligo, or melasma in Fitzpatrick skin types IV, V and VI.
11,23, 
24
  Lightening agents act mainly by inhibiting the biosynthesis of melanin.
24
  The mech-
anism of hydroquinone and mercury is based on the breakdown of melanin formation by 
competitively inhibiting the activity of the tyrosinase molecule.
25-27
  An overview of the 
inhibitory mechanism of the top 20 whitening agents is given in Section 1.1.3. 
 
Long-term exposure to skin-lightening agents has been associated with acute and chron-
ic toxicity.
26
  Hydroquinone causes contact dermatitis, exogenous ochronosis, and 
dyschromia.
29-31
  Mercury is highly toxic and continued exposure can lead to neurologi-
cal damage.
19








  Besides, it has been demonstrated that diverse 
reactions such as kidney, blood vessel and nervous system damages, miscarriage, infer-
tility in men and women, hormonal changes and behavioural problems can be induced 





shown the presence of heavy metals such as Cd, Cr, Cu, Hg, Ni, Pb in a variety of cos-
metic products ranging from facial make-up (for example, lipsticks, eye shadows, mas-
cara, eyeliners, face powder and foundation), sunscreen creams, hair dyes and shampoos.  
These reports have prompted us to determine the heavy metal content in the selected 
skin-lightening creams and to assess whether their concentrations conform to the exist-
ing regulatory limits.  
 
The cosmetic safety regulation of the European Union (EU) and the US Food and Drug 
Administration
41
 proposed that hydroquinone should not exceed 2% as an active ingre-
dient in over-the-counter (OTC) skin-lightening products and a maximum concentration 
of 4% is allowed only by prescription.  However, mercury is prohibited in any amount 
in cosmetics (Council Directive 76/768/EEC of 27 July 1976).
42
  Despite widespread 
public health campaigns and government bans of these ingredients, the practice of skin-
lightening is on-going and growing in African and Asian countries.   
 
In this study inductively coupled plasma-optical emission spectroscopy (ICP-OES), 
cold vapour atomic absorption spectroscopy (CV-AAS) and high performance liquid 
chromatography (HPLC) were used to analyse the selected skin-lightening creams. 
 
1.1 General overview of the practice of skin-lightening 
 
Black skin represents the first ethnic group in the world with a higher natural protection 
against sun damage and skin aging due to the important role of melanin in absorbing 
ultraviolet light and blocking free radical generation.
27
  But, why do many darker-
skinned people not feel confident of their inherent skin texture?  Studies argued that this 
practice had roots in the history of colonization and westernisation; as the Europeans 
dominated each part of the world, they integrated cultural beliefs that devalued darker 
skin and valued lighter skin.
15,17,18,43




psychological hierarchy based on distinctions of skin colour gained significance and 
importance within different communities around the world including Africa, Asia, 
North America and the Middle East.
14,16
 
Over the past years, the execution of this hierarchy has been realised in Africa as light-
skinned and some mixed-race descendants have occupied positions of power and eco-
nomic advantage over darker-skinned populations.  This discrimination has brought 
feelings of inferiority, poor identity, and low self-esteem within dark-skinned 
Africans.
43
  Even in other countries where pigmentation among the inhabitants is quite 
varied, such as the USA, Brazil, and Asian communities, higher socioeconomic levels 
and a greater presence in leadership positions belong to lighter-skinned individuals.
13,17
  
Furthermore, in the post-colonial era, Western influences and the mass media continue 
to reinforce differences in racial skin colour by portraying lighter skin as beautiful (the 
ideals of beauty) and preferable over darker skin.
17
   
 
In Asia, women were deeply influenced by the concept that a white complexion is pow-
erful enough to hide a number of faults as stated by various idioms such as “white skin 
can conceal seven defects” (Japanese) and “white skin can cover thousand ugliness” 
(Chinese).
18
  These ideals of whiteness motivated many Asian and African women to 
bleach their skin tone to obtain a light complexion.
12,43,44
  Nowadays, the belief that 
light skin is a key criterion for positive outcomes, beautifulness, attractiveness, higher 
status, higher level of education and others, is still true in many societies. 
 
The report of the World Health Organisation
44
 indicated that the use of skin-lightening 
products in African countries is on-going and growing, among which women are some 
of the most widely represented users.  The scores are high, for example up to 77% in 
Nigeria,
46
 52% in Senegal,
47
 44.3% in Burkina Faso,
48
 59% in Togo
46
 and 25% in 
Mali.
49
  This practice is reported also in South Africa
22
, the Democratic Republic of 







1.1.1 Biosynthesis of melanin (Melanogenesis and tyrosinase inhibitors) 
 
The biosynthetic pathway for the formation of the smaller pigmented biopolymers, mel-
anin, in human skin is called melanogenesis.
50
  Melanin is produced in melanocyte cells 
localized in the outermost layer of the skin, the epidermis.  Melanin is formed through 
the copper-based enzyme, tyrosinase, which catalyses the first two steps of melanin 
production: hydroxylation of tyrosine to 3,4-dihydroxyphenylalanine (DOPA) and the 
subsequent oxidation of dopa into dopa-quinone.  Dopa-quinone is converted to do-
pachrome through enzymatic conversions by dopachrome tautomerase, also referred to 
as tyrosine-related protein 1 and 2 (TRP-1 and TRP-2), and then to dihydroxyindole or 
dihydroxyindole-2-carboxylic acid (DHICA) to form eumelanin.  In the presence of 
cysteine or glutathione, dopaquinone is converted to cysteinyldopa or glutathionyldopa.  
Subsequently, pheomelanin is formed.  Eumelanin is a dark brown-black insoluble pol-
ymer, whereas pheomelanin is a light red-yellow sulfur-containing soluble polymer.  
Figure 1.1 shows part of the chemical structures of eumelanin and pheomelanin.  A 
combination of eumelanin and pheomelanin forms the melanin pigment.   
 








































Figure 1.1: Part of the molecular structure of pheomelanin and eumelanin (↑ shows 
where the polymer continues) [http://www.photoprotection.clinuvel.com/node/204 (Ac-
cessed on 27
th




In addition to the activity of the tyrosinase enzyme, UV radiation and genes as well as 
hormones such as alpha melanocyte-stimulating hormone (α-MSH) and adrenocortico-
tropic hormone (ACTH) have also been shown to stimulate melanogenesis.
52
  As noted 
above, tyrosinase is the enzyme that catalyses several oxidative reactions required for 
melanin synthesis from its precursor amino acid, tyrosine.
25
 It is well-known for regulat-
ing melanogenesis.  Figure 1.2 illustrates a simplified biosynthesis pathway of melanin.  






























Melanin play an important role in the absorption of free radicals generated within the 
cytoplasm and in shielding from ultraviolet radiation.
3,25
  Moreover, the overproduction 
of melanin pigment causes hyperpigmentation of the skin while a decrease of melanin 
can result in hypopigmentation.   
 
Despite the acknowledged mechanisms of melanoganesis, variations in the number, 
size, and aggregation of melanosomes within the melanocyte and keratinocyte result in 
the racial and ethnic differences in skin colour.
7,52
  The distribution pattern of synthe-
sised melanin in the epidermis determines the actual colour of the skin.
50
  Parvez et al.
27
 
mentioned that a visible pigmentation in mammals results from the synthesis and distri-




 demonstrates that different steps of the melanogenesis pathway can also be 
interrupted depending on the mechanistic reaction of the inhibitor involved.
51
  However, 
the inhibition of the enzymatic reaction of tyrosinase is still the most common approach 
to lighten the skin.
51,52
  The active compounds aimed at inhibiting melanin production 
may be of synthetic sources or botanic sources.  These compounds are currently being 
used in cosmetic products and traditional preparations. 
 
Considering the mechanism of tyrosinase inhibitory activity, skin-lightening agents can 
be classified into three types, namely, competitive, non-competitive or mixed inhibitor.
4, 
27
  Commonly used skin-lightening agents are known as competitive inhibitors of tyro-
sinase.  The competitive inhibitors are also divided into three categories: phenolic com-
pounds, non-phenolic compounds, and combination formulas.
53
 Hydroquinone (HQ) 
and its derivatives monobenzyl ether of hydroquinone (MBEH), phenol and its com-
pounds such as 4-methoxyphenol (4-MEP), 4-isopropylcatechol, 4-hydroxyanisol and 
N-acetyl-4-S-cystaminylphenol (4-S-CAP) represent the first category.
54
  The second 
category, non-phenolic compounds, includes kojic acid (KA), azelaic acid (AZA), N-
acetylcystein, tretinoin, and L-ascorbic acid (AS).
53,54
  The last category often involves 
a combination of HQ and various lightening active agents of different concentrations.  
The most commonly used combination formulas are Kligman’s formula (HQ 5%, tret-




alcoholic base cream or ointment base), Pathak’s formula (2% HQ, tretinoin 0.05–0.1% 
in hydro-alcoholic base cream or ointment base) and Westerhof’s formula (N-
acetylcysteine 3%, HQ 2%, hydrocortisone 1% in ointment base).
53
   
 
Other active compounds, such as resorcinol and its derivatives (4-butylresorcinol, 4-
phenylethylresorcinol, and 4-hexylresorcinol), mercury, and steroids have been shown 
to have a strong inhibitory effect on melanin synthesis.
26, 28, 51, 55
  In addition to these, 
many plant extracts contain active compounds, mainly arbutin, aleosin, flavonoids, gen-
tisic acid, niacinamide, licorice, and polyphenols that are also known to be inhibitors of 
melanogenesis, without melanoctyes cytotoxicity or mutagenicity.
56, 57
  Section 1.1.3 
gives more information about skin-lightening agents mostly used in cosmetics. 
 
1.1.2 Skin types  
 
The skin is a complex organ with complicated structures and mechanisms that connect it 
to the entire body.  The skin is composed of three main layers: the epidermis, dermis 
and hypoderm.
58
  The visible human skin colour results from the synthesis and 
distribution of melanin in the melanocyte cells, mainly located in the epidermis layer of 
the skin.
6, 50, 59
  It is well known that the skin plays a role in thermoregulation, protection 
against pathogens, and a barrier function for maintaining proper hydration of the body.  
Paradoxically, the skin can be seen as a mirror that reflects the integumentary system 
and is a key criterion for visual evaluation of physical appearance, attractiveness and 
beauty.  
 
1.1.2.1 Variability in skin tone 
 
Human skin colour ranges in variety from the darkest brown to pinkish-white hues.  The 
most commonly used scheme to classify a person’s skin type is by their response to sun 
exposure.  It correlates the colour of the skin with its dynamic ability to respond to UV 
light in terms of the degree of burning and tanning (see Table 1.1).  Pale skin or white 
skin burns easily and tans slowly and poorly, whereas darker skin burns less and tans 











Skin type Natural skin colour Skin reactions to solar 
radiation 
Examples 
I Pale white Always burns, never tans People with blue eyes, 
often freckled 
II Fair white Burns easily, tans mini-
mally 
People with red or 
blonde hair, blue eyes 
III Light brown Burns moderately, tans 
uniformly 
 
IV Moderate brown Burns minimally, tans 
easily 
People with dark brown 
hair, dark eyes, e.g. 
Orientals, 
Mediterranean 
V Dark brown Rarely burns, tans darkly 
easily 
East Indians, American 
Indians, Hispanics 
VI Black never burns, tans pro-
fusely 




Skin type I-III can be at risk of developing skin cancer following sun exposure whereas 
skin types IV-VI can be prone to an overactive production of melanin which can lead to 
melasma.  A skin colour chart is shown in Figure 1.3.  Therefore, all skin type I-III and 
IV-VI are advised to use appropriate sunscreen to protect themselves from harmful UV 
rays as extreme sun exposure can induce serious damage, uneven skin tone, premature 






Figure 1.3: Skin colour chart (Professor B. Martincigh, Personal Communication, 
October, 2014). 
 
Other skin classification systems consider factors such as lipid content and hydration of 
the skin, other than the sensitivity to sun light or the effect of UV radiation.  Skin types 
may vary from normal, dry, oily to combination skin.  As reported by Mercurio et al.,
63
 
skin is classified into six types: eudermic (healthy skin), oily, alipic, hydrated, 
dehydrated and combination.  Consequently, the skin type can change over time.  For 





1.1.2.2 Racial differences  
 
Understanding of various races and ethnic groups of Homo sapiens species entails the 
influence of many factors including biological or genetic traits.
6
  Obvious physical 
differences exist in hair colour, texture, skin colour and facial features.  Most studies 
evaluate racial/ethnic differences in skin structure, physiology and dermatologic 
disorders.
6, 61-64
  Research into molecular genetics describes racial differences according 





also noted that the colour of the skin is the main feature that characterises the race.   
 
Considering the pigmentation of the skin, there are many racial and ethnic groups.  For 
example, the black race or people with skin of colour.  Subsequently, skin of colour is 
also divided into skin type IV, V and VI.  The majority of this group include Africans, 
Afro-Caribbeans, Asians, and Native American and African Americans.
7
  Hispanics 
constitute another group which is included in the non-Caucasian category.  This 
includes people who are lighter in colour such as European Hispanics as well as Central 





Other reviews consider racial variability in terms of different skin responses to 
cutaneous diseases.  Blacks experience less skin irritation, as induced by either 
chemicals or UV light, compared to white persons.
66
  Though skin cancer is the most 
common malignancy, the incidence is relatively low in black-skinned people (skin type 
IV-VI).
62, 65
  The melanin content and melanosomal dispersion pattern in these people is 
thought to be responsible for providing protection from the carcinogenic effects of UV 
radiation.  However, hyperpigmentation disorder (melasma) occurs frequently in black-
skinned people and is reported to be more prevalent in Asians.
23, 69
  More information 
concerning racial/ethnic differences regarding skin reactivity in pathologic and 




Considering the complexity of skin typing, skin disorders of any sort affect most people, 
regardless of bioethnic background or skin colour.
71




For instance, skin may either appear blotchy, lighter, or darker than normal, or lack 
pigmentation.  All these conditions occur when the body produces either too much or 
too little melanin.
71
   
 
The desire for a fair tone is very common, particularly, among people with Fitzpatrick 
skin types IV to V.  However, the need for efficacious and low undesirable side-effects 
of topical preparations in the treatment of uneven pigmentation has become a 
dermatological challenge worldwide, in view of the increasing incidents of exogenous 
ochronosis.
6
  Attention is given to cosmetic products that claim to have skin-
improvement properties such us moisturisers or emollients, sunscreens and skin-
lighteners. 
 
1.1.3 Skin-lightening agents  
 
Skin-lightening agents are often applied to lighten uneven skin tone.  For medical pur-
poses these agents play an important role for the treatment of pigmentary disorders such 
as melasma, acne, age spots, and hyperpigmentation.
24, 48, 67, 70-72
  These disorders great-
ly affect populations with skin phototypes IV, V and VI, like Africans, Asians and His-
panics or darker skin people living in different countries.
26, 73-75
   
 
Hydroquinone, steroids and mercury are the ingredients widely used in skin-lightening 
products.
35
 However, these agents expose users to certain additional cutaneous risks 
among which an increase of hyperpigmentation of the skin and many other health com-
plications that reappear after discontinuation of therapy.
25
  The following is a discussion 
of the most popular skin-lightening agents reported in the literature, their known mech-
anisms of action and potential side effects. 
 
1.1.3.1 Hydroquinone and its derivatives 
 
Hydroquinone (HQ) is a phenolic compound chemically used as a reducing agent, anti-
oxidant, polymerisation inhibitor, and chemical intermediate in the synthesis of other 
antioxidant derivatives.
28
  It has been a golden standard, dermatologically, used for 






  HQ occurs naturally in coffee beans, tea, red wine, wheat and 
leaves of berries.  It is a commodity chemical also known under different synonyms 
such as 1,4-dihydroxybenzene, 1,4-diol/quinol, 1,4 benzenediol, p-benzenediol, β-
quinol, p-hydroxphenol, p-dioxobenzene, hydrochinone or tecquinol.  The structures of 
some common skin-lightening agents are shown in Table 1.2. 
 
HQ is the most conventional active ingredient used in many skin-whitening products.  It 
acts by competitively inhibiting melanin production by inhibiting sulfhydryl groups and 
acting as a substrate for tyrosinase.  Other proposed mechanisms of action include the 





Hydroquinone is the most discussed agent in the literature for its toxic effects including 
neuropathy, exogenous ochronosis and leukoderma after long-term exposure.  Conse-
quently, the European Union has prohibited the use of hydroquinone in cosmetics since 
2001.
18
  The US Food and Drug Administration  proposed that hydroquinone should not 
exceed 2% as an active ingredient in OTC skin-bleaching products.
41
  In Nigeria, the 
National Food and Drug Agency of Nigeria (NAFDAC) had initially allowed a maxi-
mum of 2% hydroquinone in bleaching creams.  However, due to the side-effects asso-
ciated with long-term hydroquinone use and also lack of compliance with content and 
labelling requirements, all forms of bleaching agents were prohibited in cosmetics and 
toiletries.
25
  Later on, the FDA released a statement proposing to consider all skin-
bleaching drug products, whether currently marketed on prescription or OTC basis, to 
be new drugs requiring an approved new drug application for continued marketing.
77
 
Since hydroquinone causes reversible inhibition of cellular metabolism by affecting 
both DNA and RNA synthesis,
4
 its derivatives were considered as possible alternative 
agents.  The most used hydroquinone derivatives, in skin-lightening products, are 
monobenzyl ether of hydroquinone (MBEH, monobenzone) and monomethyl ether of 
hydroquinone (MMEH, 4-hydroxyanisole, mequinol).
27,28, 30
  However, both compounds 
were reported to induce highly melanocytotoxic effects.
28






Table 1.2: Chemical structures of some common skin-lightening agents. 
 
































1.1.3.2 Phenol  
 
Phenol is a carbolic acid (C6H5OH) used as a peel agent to eradicate heavy wrinkles and 
lines caused by chronic photodamage and solar lentigines.
78
  It is absorbed fast through 





Other chemical peels used in cosmetics are salicylic acid and glycolic acid.  Glycolic 
acid is commonly used in cosmetic products as a peeling agent that helps to alter the 
structure and content of the skin, increasing production of collagen.  On the other hand, 
salicylic acid (o-hydroxybenzoic acid) is used as a keratolytic peeling agent and also as 
an anti-inflammatory.  It is a non-competitive inhibitor of tyrosinase.
27
   
 
Chemical peels are categorised as superficial peels (α-hydroxy acids, salicylic acids and 
Jessner’s solution contains ≤ 25% trichloroacetic acid, TCA), medium-depth peels 




1.1.3.3 Kojic Acid 
 
Kojic acid (5-hydroxy-2-hydroxymethyl-4-H-pyran-4-one) is a hydrophilic fungal 
metabolite obtained from aspergillus and penicillium species.
4
  It is a potent tyrosinase 
inhibitor that functions by chelating copper at the active site of the enzyme and prevents 




 have noted 
the efficacy of kojic acid in the treatment of melasma.  However, it is a sensitiser that 
has been found to cause allergic dermatitis and erythema.
30
  In one study kojic acid has 






Resorcinol is considered as antibacterial, anti-acne, and an effective topical disinfectant 
in concentrations of 1-3%.
77
  It (14%) is often combined with salicylic acid (14%) and 
lactic acid (14%) to treat moderate to severe facial dyschromias, acne, oily skin, textur-
ally rough skin, fine wrinkles and pseudofolliculitis.
5




rucinol and 4-n-butylresorsinol, are strong tyrosinase and TRP-1 inhibitors.
50
  Resor-






Arbutin is a derivative of hydroquinone, naturally isolated from bearberry fruit 
(arctostaphylos uva ursi).  It decreases melanin content in melanocytes by a competitive 
inhibition of tyrosinase enzyme.
81
  Although, arbutin has shown to be effective in 







Niacinamide (nicotinamide, 3-pyridinecarboxamide) is the physiologically active 
amide, niacin (vitamin B3).  Studies have shown that niacinamide is of dermatologic 
benefit in the treatment of melasma, and popular and pustular acne.
22,82
  It prevents 
melanogenesis without inhibiting tyrosinase, but by decreasing melanosome transfer 




1.1.3.7 Retinoids  
Retinoids induce skin-lightening by accelerating epidermal turnover and, therefore, they 
are used as monotherapy and in combination with other topical agents for the treatment 
of melasma.
84
  Retinoids, such as tretinoin, interrupt melanin synthesis by inhibiting 
UVB-induced tyrosinase and TRP-1 expression.
85
  Topical retinoids are associated with 
local skin irritation, ertyhrema, dermatitis and severe peeling.  Other effective retinoid 




1.1.3.8 Plant extracts 
 
Traditional herbal medicines and/or active compounds isolated from plants provide op-
portunities to develop a new approach to control pigmentary disorders.  Studies have 
found that compounds, such as aloesin, hesperidin, licorice, flavonoids, gentisic acid 




kojic acid, and arbutin.
4,56,57
  Many of these plant extracts are believed not to cause po-






Steroids (corticosteroids) are drug-based hormones widely used to control inflammation 
in the body.  Steroids that are known for improving performance by increasing muscle 
mass and decreasing body fat are called anabolic steroids. These are commonly used in 
sport.
86
  In dermatology, steroids are effective anti-inflammatory preparations used to 
control many inflammatory skin conditions including psoriasis, atopic dermatitis and 
eczema.
87, 88
  Steroids are called systemic if they are taken by mouth or given by intra-
muscular injection, and topical steroids if they are applied on the skin.  Topical steroids 
are divided into four groups: mild, moderate, potent and very potent.
88
  Mild and mod-
erate topical steroids rarely cause side-effects.  Absorption through the skin of potent 
and very potent steroids can cause local and systemic effects.  Indeed topical steroids 
are associated with complications, especially when used incorrectly.  The most reported 
side-effects associated with long-term use and over dosage include increased acne, 
rosacea, burns, stretch marks, straie, decreased skin healing and numbness, skin atrophy 
and bruising.
89-91
  It is also reported that dexamethasone and betamethasone may cause 




Corticosteroids are used in bleaching creams as an active ingredient because of their 
ability of inhibiting cAMP and decreasing the precursor for melanocyte-stimulating 
hormone.
94
  Table 1.3 lists topical steroids commonly used in skin-lightening products.  
Although these mechanisms lead to the reduction of melanin formation, sometimes ster-




Steroid formulations (0.025% to 0.5%, w/w) are prescribed and have been noted to im-
prove therapy for psoriasis conditions.
93





Table 1.3: Topical steroids mostly used in skin-lightening products. 
 
Potency Chemical structure* 
Very high 
Betamethasone 0.05% Clobetasol propionate (0.05%) 
   
High 
Triamcinolone acetonide (0.05%) Fluocinonide (0.05%) 
   
Moderate 
Hydrocortisone valerate (02%) Betamethasone valerate 0.1% 
   
Mild 
Hydrocortisone (0.5-2.5%) Dexamethasone (0.1%) 





The OTC topical products containing topical steroids and some other substances with 
skin-lightening action have been banned by different countries of Africa.  However, in 
spite of their exclusion, many anti-inflammatory products (creams and ointments) are 
legally exported from Europe to Africa.
90
  Table 1.4 lists 20 most common skin-




Mercury is well-known for its toxicity.  It is distributed in the environment by natural 
and anthropogenic sources.  Like other heavy metals, mercury can be taken into the 
body via inhalation, ingestion and skin absorption.  Mercurous chloride, also known as 
calomel, mercuric chloride and mercuric oxide are the most important mercury com-
pounds.
95
 Mercurous chloride (Hg2Cl2) is used in antiseptic salves.  Mercuric chloride 
(HgCl2) is sometimes employed as a topical antiseptic in medicine whereas in agricul-
ture it is used as a fungicide.  In the chemical industry, it serves as a catalyst in the 
manufacture of vinyl chloride and as a starting material in the production of other mer-
cury compounds.  Mercuric oxide (HgO) provides elemental mercury for the prepara-
tion of various organic mercury compounds and some inorganic salts. 
 
Two forms of mercury can be found in cosmetics.  For example, organic mercury, such 
as thiomersal and phenyl mercuric salts, is used as a cosmetic preservative in eye make-
up, cleansing products and mascara, while inorganic mercury (ammoniated mercury) 
and metallic mercury are used in some skin-lightening creams and soaps as active in-




Cases of mercury toxicity and dermatologic complications due to the use of skin-
lightening creams have been reported.
25
  The absorption of mercury through the skin 
can enhance its accumulation in tissues, and hence, impairs not only the skin but also 
various organs of the body including the kidneys, brain, central nervous system and the 
digestive system.
97
  Mercury effects on the central nervous system often cause fatigue, 
weakness, headaches, depression and insomnia.  Mercury can affect the skin, causing 
irritation, erythema, itching, reddening, rashes and cracking.
98




cause anemia, renal dysfunction and cataracts in newborns after it has been absorbed in 
the blood of a mother who uses products containing mercury during pregnancy and lac-
tation.
34





Table 1.4: An overview of the melanogenesis inhibitory mechanism of 20 most com-




 Mechanism Reference 
Hydroquinone Inhibits tyrosinase, DNA and RNA synthesis 27,67 
Monobenzone Competitive inhibitor of tyrosinase 27 
Kojic acid Chelating copper at the active site of the tyrosinase 50 
Azelaic acid Competitive and reversible inhibitor of tyrosinase 27 
Arbutin Inhibits tyrosinase and the oxidation of L-DOPA 57 
Retinoids  Inhibits UVB-induced tyrosinase and TRP-1 ex-
pression 
85 
Niacinamide Inhibits the transfer of melanosomes 101 
N-acetyl-
glucosamine 
Interferes with pigment cell growth and prolifera-
tion 
69 
Corticosteroids cAMP inhibition and decreases the precursor for 
melanocyte stimulating hormone 
26,88 
Mercury Competitively combines with tyrosinase and pre-
vents copper from binding at the active site.  
50 
Gentisic acid Its alkyl esters noncompetitively  inhibit tyrosinase 52 
Mequinol Competitive inhibitor of tyrosinase and destruction 
of pigment cells 
23 
Vitamin C Suppression of melanin formation on purified tyro-
sinase and in melanocytes 
101 
Aloesin Inhibits tyrosinase (noncompetitive) and DOPA 
oxidase activities 
25 
Hydroxystilbene Reduction in MITF and tyrosinase promoter activi-
ties (non-competitive inhibitor) 
50 
Melatonin Inhibits cAMP-driven processes in pigment cells 27 
Soy protein Inhibits the action of protease-activated receptor-2 
cleavage and reduces keratinocyte phagocytosis 
27 
Glycolic acid Inhibits melanin formation in human melanoma 
cells without affecting tyrosinase 
25 
Green tea Competitively inhibits tyrosinase activities 55 
Licorice Competitively inhibits tyrosinase activities 57 
cAMP: cyclic adenosine-3,5-monophosphate; DOPA: dihydroxyphenylalanine; MITF: 





1.1.4 Heavy metals 
 
Heavy metals refer to those metals with a density at least five times greater than that of 




  They occur naturally in the environment and become concentrated 
as a result of human activities.  Common sources are mining, rocks, soil and water as 
well as the manufacture of pigments and other raw materials in all industries.  Examples 
of metals classified as heavy metals include: antimony, arsenic, bismuth, cadmium, 
selenium, chromium, cobalt, copper, gallium, gold, iron, lead, manganese, mercury, 
nickel, platinum, silver, tellurium, thallium, tin, uranium, vanadium and zinc.  
Contamination by these metals is an environmental and health issue. 
 
Heavy metals in various media have been widely studied because of their detrimental 
health effects and the fact that they are persistent and bioaccumulate. 
 
1.1.4.1 Heavy metals in cosmetics  
 
Cosmetics include any preparation intended to be rubbed, poured, sprinkled or sprayed 
on the human body for beautifying, promoting attractiveness, or altering the appearance 
of the skin, by the removal or correction of blemishes.
93
  They can also be used to 
prevent skin diseases, to repair or hide skin imperfections, to cleanse, decorate, protect 




Common cosmetic formulations include skin-care creams, lotions, powders, sprays, 
perfumes, lipsticks, nail polishes, eye and facial makeup, hair colours, shampoos, soaps, 
deodorants, bath and shower oils, toothpaste, and sunscreens.  Cosmetics are made from 
a range of organic or inorganic ingredients, which are deemed to be industrial chemicals.   
The US FDA has banned heavy metals and their compounds from being intentionally 
added to cosmetics, unless they occur as impurities.
41
  However, the impurities are still 
a cause of concern in case they are not well controlled.  For instance, heavy metals can 
be present in makeup because they are part of the raw ingredients used to make the 
product.  On the other hand, some equipment used can occasionally contaminate the 
product during the manufacturing process.  In this case, the impurities will not be 





Therefore, impurities should also be monitored as detrimental chemicals in many 
cosmetic products.  People may think that these impurities are not important since these 
products are applied on the skin.  However, since the skin is the thinnest and most 
highly permeable organ that covers all the body, it allows penetration of different 
substances to the bloodstream and thereby to the rest of the body.  
 
1.1.4.2 Health impact of heavy metals in cosmetics 
 
Some heavy metals have no function in the body and can be highly toxic.  However, 
others are essential for maintaining human health.  Iron, copper, zinc, cobalt and 
manganese are well known essential elements for biological systems.  For example, iron 
is needed for the production of red blood cells and also for the transportation of oxygen 
from the lungs to the heart.  Copper participates in biological oxidations through 
enzymes and proteins containing this element.  Zinc helps wound healing, and is 
essential for normal growth of all tissues.
103
  Cobalt is a part of vitamin B12, which 
serves to hold the vitamin molecule together and to make it function properly.  At high 
levels cobalt can harm the lungs and heart or cause dermatitis.
104
  Essential metals in the 
human body normally are needed at low concentrations; deficiency or excessive 




Heavy metals enter the human body primarily via diet, air inhalation and skin exposure.  
The use of different cosmetics such as skin-lightening creams, facial make-up and nail 
polishes may represent another potential source of contamination as they are applied 
directly to the skin.
38, 93, 104-106
  Long-term exposure to heavy metals can lead to their 
accumulation in organisms because they are hard to metabolise.  Studies have shown 
that metal ions, when bound to proteins, enzymes, and nucleic acids get absorbed and 
interfere by forming complexes with carboxylic acids (–COOH), amines (–NH2), and 
thiols (–SH) of proteins resulting in malfunctioning or death of the cells.
107-109
  




Heavy metals have been found as impurities in several cosmetic products.
111




instances, they have been intentionally used as cosmetic ingredients as colour additives, 
preservatives and/or active agents.  Examples include mercury for inhibiting melanin 
production,
112
 thiomerosal as a mercury-based preservative and lead acetate as a 
progressive hair dye,
113
 red cinnabar (mercuric sulfide) as tattoo pigments, and 
cadmium as a deep yellow to orange pigment for lipsticks and face powders.
113
   
 
Given that the health issues of heavy metals as deliberate cosmetic ingredients have 
been addressed, attention is turned to the presence of these substances as impurities.  
Lead, arsenic, cadmium, chromium and mercury are the most reported metals of 




As mentioned previously, mercury is linked to kidney damage, and reproductive system 
and central nervous system disorders.
115
  Lead has been proven to cause miscarriages, 
infertility in men and women, hormonal changes and behavioural problems.
35
  Cadmi-
um impairs kidneys, lungs, blood vessels, suppresses the immune system and causes 
bone degradation.
38, 39
  Other heavy metals also present the same risk of toxicity to a 




The European Directive 76/768/EEC banned Pb, Cd, Co, Cr, Ni and their compounds in 
cosmetic preparations.
36, 116
  There is a general belief that even with the regulation of 
ingredients in cosmetic products, there are still health concerns regarding the presence 
of harmful materials within these preparations.  Therefore, there is a need to investigate 
the concentration of toxic metals in some commonly used skin-lightening preparations. 
 
In the present study, 10 elements: As, Cd, Co, Cr, Cu, Fe, Hg, Ni, Pb and Zn were quan-
titatively investigated in 49 skin-lightening creams by inductively coupled plasma- opti-
cal emission spectrometry.   
 
1.2 Dermatological effects of skin-lightening products 
 
As noted earlier, the active ingredients commonly used in many skin-lightening creams 




concentrations.  The most reported skin problems are: exogenous ochronosis, allergic 
contact dermatitis, straie atrophicans, skin atrophy or thinning, acne, pigmented colloid 
millia, nail pigmentation, skin peeling and redness, patchy, erythrema, hyperpigmenta-
tion and hypopigmentation, folliculitis, Cushion’s syndrome, pityriasis, bleach panda 
effect (heavy pigmentation around eyes), eczema, wrinkles, rosacea, and tinea.  Some of 







































Figure 1.4: Skin conditions: (a) ochronosis and steroid dermatitis, (b) acne induced by 
topical application of steroid-based cream, (c) severe ochronosis, (d) periobiatal 
pigmentation, (e) steroid rosacea, and (f) steroid straie.  (Source: Dr N Dlova, Nelson 
Mandela School of Medicine, University of KwaZulu-Natal) 
 
 
1.3 Motivation, objectives and outline of the study 
 
Everybody at some point has a problem with their own skin, whether it concerns 
pigmentation, texture, or any other skin problem.  However, the practice of skin-
(d) 
 (a)  







lightening in an attempt to beautify and achieve a moderate complexion may lead either 
to self-esteem or self-hatred.  In view of the increasing incidence of undesirable side-
effects, including exogenous ochronosis, contact dermatitis, dyschromia, nephrotic 
syndrome, and other potential health risks, that have been reported to be associated with 
long-term use of skin-lightening creams containing hydroquinone, mercury and steroid- 
based products, it is necessary to investigate whether hydroquinone and other toxic 
compounds are still among the ingredients of commercial skin-lightening creams. 
 
In this study, we investigated some commonly used skin-lightening creams available in 
South Africa’s stores.  The main objective of the study was to identify and quantify the 
active ingredients as well as heavy metals in these products.  It is well known that heavy 
metals can intentionally or unintentionally be added to cosmetics during the process of 
manufacturing.   
 
An investigation of skin-lightening creams is important not only for the compliance of 
their active ingredients with the regulations, but also for the protection of the users and, 
in particular, for public awareness about the dangers of possible toxic ingredients of 
these skin-lighteners. 
 
The analysis of skin-lightening cream samples for the organic active skin-lightening 
ingredients was carried out by using high performance liquid chromatography (HPLC).  
For the determination of mercury and heavy metals, cold vapour atomic absorption 
spectroscopy (CV-AAS) and inductively coupled plasma-optical emission spectroscopy 









In this chapter, we present the analytical techniques employed during the investigation 
of commonly used skin-lightening creams (SLCs), including an overview of the instru-
ments used, principles and experimental detail.  This chapter also outlines the consuma-
ble materials and other equipment used for the preparation, characterisation, and quanti-




A total of 60 products were purchased from various shops and beauty stores in Durban, 
South Africa.  During the collection of these products, we noticed that the package la-
bels of most of them advertise and call for consumers to safely beautify their skin tex-
ture and/or enhance the colour of the skin.  Collected sample creams were divided in 
two sets entitled Batch I and Batch II. 
 
Batch I was selected for the analysis of heavy metals and Batch II was tested for the 
presence of organic active ingredients.  All samples were stored out of sunlight and at 
room temperature in order to prevent photo-reaction and denaturation of their chemical 
constituents.  A list and details of the products investigated in this project is given in 
Table 2.1.  The chemicals used in this investigation as well as the manufactures and the 








Table 2.1: Details of skin-lightening products investigated in this study. 
 
BATCH I 














- IMC South Africa 





nal Skin Repair Cream 
Pure tissue oil, herbal extracts, vitamin A, vitamin E, Vitamin B complex, moisturi-




SLC5 Beta Cream Notice: Avoid sunlight exposure 





Bio Clear Nourishing 
Cream enriched with aloe 
vera & tea tree oil 
Aloe vera and tea tree oil cmg Trading South Africa 
SLC7 
Bio Clear Vanishing 
Cream Oil Control For 
combination to oily skin 
Pure plant extracts cmg Trading South Africa 
SLC8 Bio-Oil 
Paraffinum liquidum, triisononanoin, cetearyl ethylhexanoate, isopropyl myristate, 
retinyl palmitate, helianthus annus seed oil tocopheryl acetate, anthemis nobilis flower 
oil, lavandula angustifolia oil, rosmarinus officinalis leaf oil, calendula officinalis 
extract, glycerine soja oil, BHT, parfum, coumarin, eugenol, farnesol, purcellin oil, 
citronellol, amyl cinnamal, geraniol, limonene, linalool, CI26100, CI60725  
Evolabs (pty) 






Caro light lightening 
beauty cream with carrot 
oil 
Petrolatum, mineral oil, stearic acid, cetearyl alcohol, isopropyl miyristate, glycerin, 
methyl and propyl paraben, carrot oil, vitamin E (0.2%), hydroquinone (max. 2%), 
aqua, fragrance. 






Clear Essence skin 
smoothing crème with 
sunscreen 
Deionized water, petrolatum, cetyl alcohol, isopropyl palmitate, stearic acid, ammoni-
um lauryl sulfate, licorice extract, aspergillus ferment, ethoxydiglycol, glyceryl stea-
rate, dimethicone, diazolidinyl urea, methyl paraben, propyl paraben,  propylene gly-
col, sodium metabisulfite, octyl methoxycinnamate, lactic acid (an alpha hydroxy ac-
id), trisodium EDTA, propylene glycol, BHA, propyl gallade, citric acid, ascorbic 
acid, fragrance.  







Phenol 0.160 g, precipitated sulphur 0.500 g, 8-hydroxyquinoline 0.050 g, perfumed 
base to 100 g 
NOVARTIS South 




Cream for all skin types, 
oil reduction programme 
Aqua, stearic acid, propylene glycol, glyceryl stearate, myristyl myristate, isopropyl 
palmitate, disodium edetate, potassium hydroxide, butylparaben, ethylparaben, isobu-
tylparaben, methylparaben, phenoxyethanol, propylparaben, fragrance 
NOVARTIS Con-
sumer Health SA 
South Africa 
SLC13 
Dabur Uveda complete 
fairness cream SPF 20 
Extracts of Javetri, Kasturimanjal, Kesar and Raktachandan, glycerin, OMC, MBBT Dabur India Ltd. India 
SLC14 Epimax Cetomacrogol Genop SA South Africa. 
SLC15 
Eraser Plus anti-marks + 
fairness cream non-
greasy  
Each 100 g contains: Curcuma longa Linn 18.0 ml, Rosa centifolia Linn 4.0 ml, wheat 
germ oil 2.5 ml, Ocimum sanctum Linn 2.0 ml, citrus sinensis rind 2.0 ml, Aza-
dirachta indica oil 2.0 ml, Santalum album Linn 1.0 ml, aloe vera 1.0 ml, Crocus sa-
tivus Linn 0.1 g, Non-greasy base q.s.  
Notice: Discontinue the use if skin irritation occurs 






dic fairness cream 
Each 100 g contains: Haldi oil 1 ml, neem 1 g, safed chandan 0.5 g, santra 2 g, gulab 2 
g, aloe vera 2 g, kumkum 0.1 g, akhrot 1 g, jasmine 0.5 g non-greasy cream base q.s.  
Melanin disperser 
 - Kumkum and Sandal, Moisturiser and sunscreen - aloe vera, Nourisher 
 - Akhrot, Blemishes remover 
 - Santra and jasmine, Improves complexion 
 - Haldi and rose. 
Notice: Contains no bleach or harmful ingredients. 
IPSA Labs (P) Ltd. India 
SLC17 
Eskamel acne and pimple 
cream 
Resorcinol 2 g, sulphur 8 g, hexachlorophene 0.25 g per 100 g. 
Group Laborato-




SLC18* Eucerin 10% Urea  Beiersdorf AG Germany 
SLC19* 
Fair & Lovely advanced 
multi vitamin daily fair-
ness expert 
Water, palmitic acid and stearic acid, niacinamide, glycerin, cetearyl ethlhexanoate 
and isopropyl myristate, ethylhexyl methoxycinnamate, butyl methoxydibenzoylme-
thane, hydroxystearic acid, sodium ascorbyl phosphate, tocopheryl acetate, allantoin, 
pyridoxine hydrochloride, cetyl alcohol, dimethicone, titanium dioxide and aluminium 
hydroxide and stearic acid, phenoxyethanol, methylparaben, propylparaben, potassium 
hydroxide, titanium dioxide and dimethicone, disodium EDTA, CI 77491 (and) iso-
propyl titanium triisostearate (and) triethoxysilylethyl polydimethylsiloxyethyl dime-
thicone, CI 15510, CI 17200, perfume. 





Paris Fair & White 
Eclaircissante Whitening 
Cream 
Aqua (water), paraffinum liquidum (mineral oil), cetearyl alcohol, cera microcristalli-
na, petrolatum, polysorbate-60, glycerin, sorbitan stearate, stearic acid, parfum (fra-
grance), triethanolamine, caprylic/capric triglyceride, diacetyl boldine, propylparaben, 
methylparaben, carbomer, myrtrimonium bromide, methylchloroisothiazolinone, ben-
zyl salicylate, cinnamyl alcohol, limonene, eugenol, alpha isomethyl lonone, hexyl 
cinnamal, isoeugenol, butylphenyl methylpropional, linalool. 
Labo. DERMA France 




SLC22 Fem Bleach Cream 
Hydrogen peroxide, propylene glycol, stearic acid, glyceryl mono stearate, cetomacro-
gol-1000, isopropyl myristate, disodium EDTA, glycerin, Brij 786, cetosteryl alcohol, 
ortho-phosphoric acid, disodium maleate, water. 




Fem perfumed blue acti-
vator powder 
Persulphate, starch, colloidal silicon dioxide, di-sodium EDTA, mineral oil, ZLSS 
carbonate, metal stearate, colour blue, perfume. 
FEM Care Pharma 
Ltd. 
India 
SLC24 Fem post-bleach cream 
Stearic acid, cetyl alcohol, isoprppyl myristate, sodium stearoyl lactylate, glycerin, 
propylene glycol, methyl paraben, propyl paraben, triethanolamine, titanium dioxide, 
perfume, water q.s. 
FEM Care Pharma 
Ltd. 
India 
SLC25 Fem pre-bleach gel 
Hydrogen peroxide, carbomer, glycerin, methyl paraben, propyl paraben, me-
tamethoxy benzamide, disodium EDTA, tetrasodium pyrophosphate, sodium hexa-
metaphosphate, triethanolamine, citric acid, disodium maleate, water. 
FEM Care Pharma 
Ltd. 
India 
SLC26* Gentle Magic cream -  Du Marc cc South Africa 
SLC27 
He Man complexion 
lotion 
- Adcock Ingram South Africa 









Lemon Lite Complexion 
Cream with real lemon 
extract, Vitamin A, E & 
F Complex, SPF5  
Water, stearic acid, glycerin, ethylhexyl methoxycinnamate, triethanolamine, sodium 
borate, cetyl alcohol, isopropyl myristate, ethyl linoleate, tocopheryl acetate, Helian-
thus annuus, retinyl palmitate, retinyl acetate, methyl paraben, propyl paraben, Citrus 






Royal New You anti 
blemish fairness cream 
with green tea extract 









E, softens, smoothes & 
relieves dry skin, 
smoothes marks, tones 
skin 
Water (aqua), theobroma cacao (cocoa) extract, glyceryl stearate, petrolatum, propyl-
ene glycol, glycerin, cocos nucifera (coconut) oil, mineral oil (paraffinum liquidum),  
behentrimonium methosulfate, cetearyl alcohol, cetyl alcohol, theobroma cacao (co-
coa) seed butter, elaeis guineensis (palm) oil, dimethicone, tocopheryl acetate, fra-
grance (parfum), hydroxyethylcellulose, PEG-8 stearate, methylparaben, propylpara-
ben, benzyl alcohol, yellow 5 (CI 19140), orange 4 (CI 15510). 
E.T. Browne Drug 
Co., Inc. 
USA 
SLC33* Pure Cream 
Purified water, propylene glycol, glycerin, cetyl alcohol, ceteareth 20, ricinus commu-
nis seed oil, hydrogenated castor oil, beeswax, copernicia cerifera wax, capryli-
ric/capric triglyceride, isopropyl myristate,  cetostearyl alcohol, polysorbate 20. Pre-
served with ethylhexylglycerin and phenoxyethanol.  
Reitzer Pharma-
ceuticals (Pty) Ltd. 
South Africa 
SLC34 Pure Perfect Parfait(24)  
Aqua (water), butylene glycol, squalane, caprylic/capric triglyceride, PEG-60  almond 
glycerides, kojic acid dipalmitate, saccharomyces/xylinum black/tea ferment, arbutin, 
propylene glycol, diacetyl boldine, dimethylmethoxy chromanyl palmitate, caesalpinia 
spinosa oligosaccharides, caesalpinia spinosa gum, tocopherol, phenoxyethanol, ami-
nomethyl propanol, caprylyl glycol, acrylates/C10-30 alkyl acrylate crosspolymer, 
glycerin, hydroxyethylcellulose,parfum (fragrance), benzyl salicylate, butylphenyl 
methylpropional, citronellol, geraniol, hexyl cinnamal, hydroxyisohexyl 3-
cyclohexene carboxaldehyde, limonene, linalool, CI 17200 (Red 33). 
Pure Perfect cc South Africa 
SLC35 Pure Perfect Parfait(25)  
Aqua (water), butylene glycol, squalane, caprylic/capric triglyceride, PEG-60  almond 
glycerides, kojic acid dipalmitate, saccharomyces/xylinum black/tea ferment, arbutin, 
propylene glycol, diacetyl boldine, dimethylmethoxy chromanyl palmitate, caesalpinia 
spinosa oligosaccharides, caesalpinia spinosa gum, tocopherol, phenoxyethanol, ami-
nomethyl propanol, caprylyl glycol, acrylates/C10-30 alkyl acrylate crosspolymer, 
glycerin, hydroxyethylcellulose,parfum (fragrance), benzyl salicylate, butylphenyl 
methylpropional, citronellol, geraniol, hexyl cinnamal, hydroxyisohexyl 3-
cyclohexene carboxaldehyde, limonene, linalool, CI 17200 (Red 33). 
Pure Perfect cc South Africa 
SLC36 Pure Perfect Parfait(6) 
Aqua (water), butylene glycol, squalane, caprylic/capric triglyceride, PEG-60  almond 
glycerides, kojic acid dipalmitate, saccharomyces/xylinum black/tea ferment, arbutin, 
propylene glycol, diacetyl boldine, dimethylmethoxy chromanyl palmitate, caesalpinia 
spinosa oligosaccharides, caesalpinia spinosa gum, tocopherol, phenoxyethanol, ami-
nomethyl propanol, caprylyl glycol, benzyl salicylate, butylphenyl methylpropional, 
citronellol, geraniol, hexyl cinnamal, hydroxyisohexyl 3-cyclohexene carboxaldehyde, 
limonene, linalool, CI 17200 (Red 33). 




SLC37 Pure Perfect Parfait (7) 
Aqua (water), butylene glycol, squalane, caprylic/capric triglyceride, PEG-60  almond 
glycerides, kojic acid dipalmitate, saccharomyces/xylinum black/tea ferment, arbutin, 
propylene glycol, diacetyl boldine, dimethylmethoxy chromanyl palmitate, caesalpinia 
spinosa oligosaccharides, caesalpinia spinosa gum, tocopherol, phenoxyethanol, ami-
nomethyl propanol, caprylyl glycol, benzyl salicylate, butylphenyl methylpropional, 
citronellol, geraniol, hexyl cinnamal, hydroxyisohexyl 3-cyclohexene carboxaldehyde, 
limonene, linalool, CI 17200 (Red 33). 
Pure Perfect cc South Africa 
SLC38 Pure Perfect Parfait (8) 
Mulberry extract, lactic acid, safflower oil, stearic acid, carbomer, ploydecene, glycer-
ol stearate, benzoyl alcohol, methlisothiazolinone, undecylenoyl phenylalanine 
(SEPIWHITE MSH), kojic acid, licorice root extract, dimethicone, cetearyl alcohol, 
macadamia (vitamin E), fragrance 
Pure Perfect cc South Africa 
SLC39 
Queda Amabala day and 
night cream plus skin 
conditioner now with sun 
protector 
 Notice: Avoid excessive exposure to sunlight while using this product Adcock Ingram  South Africa 
SLC40 






Replay Skin Care Day 
Cream 
SPF 15 
Notice: Mild stinging may occur at first. Discontinue use if irritation occurs. 




Replay Skin Care Night 
Cream 
Notice: Mild stinging or itching may occur. If this persists or other irritation occurs 
discontinue use. 




Rico lemon X-TRA skin 
lightening complexion 
cream 
Aqua (water), glyceryl stearate, cetearyl alcohol, glycerin, dipropylene glycol, betula 
alba, glycyrrhiza glaba, citrus limonum, sambucus nigra, tilia cordata, morus nigra, 
isopropyl myristate, sodium lactate, fragrance (parfum), ethylhexyl methox-
ycinnamate, tocopheryl acetate (vitamin E), allantoin, ascorbic acid, sodium lauryl 
sulfate, sodium metabisulfite, disodium EDTA, methylparaben, propylparaben, p-
chloro-m-cresol.  
Notice: If skin irritation occurs discontinue use.  Not suitable for sunburn prevention.  
This crem should not be used by children under the age of 12 without the advice of a 
doctor. 
 







Purified water, propylene glycol, glycerin, cetyl alcohol, ceteareth 20, ricinus com-
munis seed oil, hydrogenated castor oil, beeswax, lactic acid triethanolamine, caprylir-
ic/capric triglyceride, isopropyl myristate,  cetostearyl alcohol, polysorbate 20. Pre-
served with ethylhexylglycerin and phenoxyethanol. 
Reitzer Pharma-
ceuticals (Pty) Ltd. 
South Africa 




SLC46 Skinspor GS - Mthatha Pharmacy  - 
SLC47 
Susa Amabala Vanishing 
Cream with oil control 
ingredients 
Water (aqua), stearic acid, propylene glycol, niacinamide, cetearyl alcohol, sodium 
C8-16 isoalkylsuccinyl, soy protein sulfonate, cyclomethicone, lauryl methacry-
late/glycol dimethacrylate crosspolymer, triethanolamine, fragrance (parfum), 
ethylhexyl dimethyl PABA, DMDM hydantoin, tocopheryl acetate, menthol, camphor, 
amyl cinnamal, butylphenyl methylpropional, citral, citronellol, coumarin, geraniol, 
hexyl cinnamal, hydroxisohexyl 3-cyclohexene carboxaldehyde, limonene, linalool 
Amka Products South Africa 






Hydroquinone Free, Candellila wax, Carnauba wax, castor oil, salicylic acid, to-
copheryl acetate, titanium dioxide, licorice extract, co-enzyme Q10 





e Beauty Vanishing 
Cream for long lasting 
oil and shine control, 
advanced formula with 
vitamins E and B3 for a 
beautiful complexion, 
normal to oily skin types 
Aqua, stearic acid, niacinamide, glycerine, propylene glycol, silica, ethyhexyl adipate, 
dimethicone, carbomer, ceto stearyl alcohol, ethylene glycol monostearate, tocopheryl 
acetate, parfum, potassium hydroxide, methylparaben, propylparaben, disodium 
EDTA, DMDM hydantoin. 
The E Manufac-






Naturoriché Skin Life 
Cream Turmeric Cream 
Aqua, stearic acid, aloe barbadensis (aloe vera), Ocimum Sanctum (Tulsi), Rubia Cor-
difolia (Manjishta), berberis species (Daru Haldi), Curcuma long extract (Haldi), tu-
meric oil, glycerin (glycerol), cetyl alcohol, methylpara hydroxy benzoate, propyl para 
hydroxy benzoate, EDTA, butyl hydro toluene, dimethicone (silicone oil), vitamine E, 
potassium hydroxide, parfum, colour-Tartazine Yellow (CI No. 19140), sunset yellow 
FCF. 
Notice: Before using on face, test cream on a small section of arm or leg, if irritation 
occurs discontinue use.  Contact physician. 
Hesh Pharma India 
SLC52 
Seven Herbal Ubtan with 
sunscreen makes the skin 
radiant and fair 
Pure herbs C.P.H.L. Pakistan 
SLC53 
Mod Girl Fairness Snow 
with sunscreen multi-
protection SPF 15 
SPF 15 
Max-Zealer Cos-
metics (Pvt) Ltd. 
Pakistan 
SLC54 
Skin White Golden 
Beauty Cream 
No steroids, no mercury, no side effects                                                                                                                     
Natural beeswax, petrolatum, zinc oxide, titanium dioxide, kojic palmitate, ar-
butin/plant and flower extracts, octyl methoxy cinnamate, gold pigment, color and 
fragrance. 
Skincare Company Pakistan 
SLC55 Movate Cream 
100 g contains: Clobetasol propionate 0.050 g, Excipients: propylene glycol, titanium 






G & G Lightening Beau-
ty Cream with D.S.N. 56 
for all skin types with 
sun rays filters 
Aqua (water), stearyl alcohol, petrlatum, (paraffin), paraffinum liquidum (mineral oil), 
kojic acid, artosphylos UVA-URSI (Bearberry extracts), isopropyl myristate, glycerin, 
1% octylmethoxycinnamate,AHA (citric, gluconic, glycolic, lactic, malic, salycilic, 
tartaric acids), cyclomethicone, sodium metabisulfite, fragrance, Simondsia, Chinensis 
(Jojoba oil),triticum vulgare (wheat germ oil), propyl paraben, cetyl alcohol, , methyl 
paraben, polysorbate 60, 0.5% butylmethoxydibenzoylmethane, BHT, tocopheryl ace-
tate, 3% D.S.N. 56 (kojic acid and bearberry extracts). 
Notice: In case of irritation, stop application. Do not use for children under 12 years 
old. 




SLC57 Eraser Anti Marks Cream 
Each 1000 g contains: wheat germ oil 2.5 g, curcuma longa linn 18.0 g, azadirachta 
indica oil 2.0 g, santalum album linn 1.0 g, Ocimum sanctum linn 2.0 g, citrus sinensis 
rind 2.0 g, rosa centifolia linn 4.0 g, aloe vera 1.0 g, crocus sativus linn 0.1 g, cream 
base q.s. 
Notice: Contains no bleach or harmful ingredients. 
Discontinue  use if skin irritation occurs 
IPSA Labs (P) Ltd. India 
SLC58 
Bio Claire Lightening 
Body Cream without 
Hydroquinone 
Water, mineral oil, petrolatum, lanolin, stearic acid, cetyl-stearylic, alcohol, isopropyl 
myristate, tocopheryl acetate, BHT, methyl paraben, propyl paraben, sodium lauryl 
sulfate, sodium metabisulfite, sodium sulfite, citric acid, propylene glycol, arctostaph-
ylos, bearberry extracts, mulberry extracts, licorice extracts, lemon extracts, kojic acid, 
fragrance. 
Notice: If skin is irritated sto use. Do not use for children under 12 years old. 
NP Gandour Ivory Cost 
SLC59 Even Tone Cream -  - India 
SLC60 
Dr James Flower Bleach-
ing Cream 
Tricosan, allantoin, Vitamin E 




Batch I: Sample products analysed for heavy metal content. 
Batch II: Sample products analysed for organic skin-lightening active ingredients. 





2.3  Extraction of heavy metals in skin-lightening creams  
 
With the development of modern analytical chemistry, the speed, precision and accura-
cy of sample analysis have been improved considerably.  These means are based not 
only on the instrumentation but also on the treatment of the matrix of the sample.  Most 
samples with a complex matrix are difficult to handle during the extraction process.  
Reports have revealed that the matrix of cosmetic creams is not simple because it con-
sists of an emulsion containing a mixture of organics and inorganics.
117
  This mixture is 
mainly composed of water, oil or a silicone phase.
104
  Oil often refers to an overall mix-
ture of chemicals including proteins, waxes and alkaloids, which demand more consid-
eration throughout the sampling processes.  The methods reported in various studies use 
acid digestion, calcination and ultrasound-assisted emulsification as sample treatment.
37-
39,104,106,118
  Sometimes, even with these treatments, complete solubilisation of a sample 
is not feasible.  The residuals (metallic oxides and pigments) that can affect the analysis 
must be removed by means of filtration or centrifugation.
104,119
  In the present study, 
acid digestion techniques were employed for the dissolution of heavy metals in skin-
lightening creams, subsequent to sampling and sample preparation, in order to com-
pletely transform the analytes into solution that can be introduced into the ICP-OES or 
CV-AAS in liquid form. 
 
2.3.1. Open acid digestion 
 
It was desirable to first carry out a preliminary test in order to assess the safety and effi-
ciency of the mineralisation method. Consequently, open acid digestion and closed acid 
digestion (microwave digestion) were conducted on five different cream samples.  
Thereafter, the digestion technique with the optimum conditions was applied to all 
cream samples. 
 
The open acid digestion method known as wet digestion and the dry ashing procedure 
were performed in order to extract metals from the matrix of the samples.  The proce-





Dry-ashing approach  
Dry ashing in an electric furnace was conducted on the selected sample creams.
38
  A 
sample mass of 0.5 g of each skin-lightening cream was accurately weighed into a fused 
silica crucible.  To avoid charring of certain samples that can happen when subjected to 
high temperature in the furnace, samples were left to dry overnight in an oven at 90 ºC.  
The sample was then heated in an electrical furnace at 600 ºC for three hours to obtain a 
carbon free ash.  The ash was allowed to cool down to room temperature in a desiccator 
and the resultant mass (approximately 0.18 g) was recorded for each sample.  For the 
next stage, all the accurately weighed ash was dissolved in 3 mL of hot conc. HNO3 and 
then the mixture was accurately diluted to 50 mL in a volumetric flask with double-
distilled water. 
 
Wet digestion approach 
Wet digestion of the samples was carried out by using a hot plate.  A mass of 0.25 g of 
each cream sample was directly placed in a beaker into which 10 mL of conc. HNO3 
was added.  The mixture was heated at 130 ºC for one hour in a fume hood.  After cool-
ing, the solution was transferred into a 50 mL volumetric flask and diluted to volume 
with double-distilled water.  The results of both dry-ashing and the wet digestion ap-
proaches are discussed in Chapter 3, Section3.1.1. 
 
2.3.2. Microwave-assisted digestion 
 
Microwave irradiation has allowed scientists to systematically study the decomposition 
mechanism of a variety of matrices in closed-vessels.  Decomposition of most samples 
can be achieved with the aid of mineral acids, primarily HNO3, HCl, HF, H2SO4 and 
other liquid reagents such as hydrogen peroxide.  Microwave digestion involves irradia-
tion with electromagnetic waves with a high frequency electric field to achieve fast 
heating of the sample through the direct absorption of microwave energy by substances.  
The higher temperature gained results in a dramatic increase in the reaction kinetics that 





Depending on the matrix of the sample, a combination of acids such as HNO3, HCl 
and/or HF, has been reported to provide better recoveries for digestion of some cosmet-
ics such as eye shadows, eyeliner and lipsticks in a closed system.
117
  However, when 
this combination was used for the skin-lightening creams in this work, it was prone to 
explode.  Consequently, in this study, a strong oxidising agent, HNO3, was chosen to 
digest skin-lightening creams.  The extraction of all selected heavy metals was then ac-
complished by a Mars 6 microwave digestion system (CEM Corporation, USA). 
 
A sample mass of 0.250 g of each skin-lightening cream was accurately weighed into a 
high pressure resistant TFM-vessel, to which 10 mL of conc. HNO3 was added.  After 
pre-digestion of samples for 15 minutes in uncovered microwave vessels placed in the 
fume hood, the vessels were sealed and subjected to microwave irradiation by using the 
program shown in Figure 2.1a. 
 
During the ramp period, the temperature was gradually increased from room tempera-
ture to 201 ºC over 20 minutes.  The vessels were held at this temperature for 15 
minutes and then cooled down to ± 65 ºC over 15 minutes.  After cooling to room tem-
perature, the vessel modules were disassembled.  Both lids and vessels were washed 
with double-distilled water while collecting the digests.  The digested samples were 
then filtered through filter paper (Whatman №1) into 50 mL volumetric flasks and di-
luted to volume with double-distilled water.  It was necessary to filter all samples in 
order to ensure that any residue, which could result in data fluctuation, was removed 
before analytical measurement.  Samples and blanks were digested in triplicate.  Both 































Figure 2.1 (a) The outline of the program used for sample digestion.  (b) Photograph of 
the microwave device and the XP-1500 TFM reaction vessels used. 
 
 































2.4 The determination of heavy metals in skin-lightening creams 
 
Skin-lightening creams were analysed for As, Cd, Co, Cr, Cu, Fe, Hg, Ni, Pb and Zn by 
inductively coupled plasma-optical emission spectrometry (ICP-OES).  This technique 
was preferred for analysis because it allows multi-element analysis and supports a wide 
linear calibration range.  Afterwards, a very sensitive method for the atomic absorption 
analysis of mercury cold-vapour atomic absorption spectrometer (CV-AAS) was also 
used for measuring trace amounts of mercury detected by ICP-OES.   
 
All glassware and plastic-ware needed for analysis were placed overnight in dilute nitric 
acid (10% HNO3) and washed with warm soapy-water, and then rinsed with distilled 
water before use.  
 
2.4.1 Inductively coupled plasma-optical emission spectrometry 
 
Inductively coupled plasma-optical emission spectrometry (ICP-OES) is an analytical 
technique used for the detection of trace metals.  It is a type of emission spectroscopy 
that uses the inductively coupled plasma to produce excited atoms and ions that emit 
electromagnetic radiation at wavelengths characteristic of a particular element.  The 
intensity of emission is indicative of the concentration of the element within a sample. 
 
The ICP-OES is composed of two parts: the ICP torch and the optical spectrometer. The 
ICP torch consists of three concentric tubes made of quartz.  The copper coil that sur-
rounds the top end of the torch is connected to the radio frequency (RF) generator. 
 
The inductively coupled plasma used in OES consists of a high temperature discharge 
generated by flowing a conductive gas (argon) through a magnetic field induced by a 






More specifically, when the torch is turned on, an intense electromagnetic field is creat-
ed within the coil by the high power radio frequency signal flowing in the coil.  The 
argon gas flowing through the torch is ignited with a Tesla unit that creates a brief dis-
charge arc through the argon flow to initiate the ionization process.  The argon gas is 
ionized in the intense electromagnetic field and flows in a particular rationally symmet-
rical pattern towards the magnetic field of the RF coil.  Stable, high temperature plasma 
is then generated as the result of the inelastic collisions created between the neutral ar-
gon atoms and the charged particles.  The characteristic emission lines of the atoms and 
ions are dispersed by a monochromator or polychromator and the intensity of these lines 
is detected, measured and compared to the intensities for known standards to provide 
quantitative results. 
 
An ICP-OES spectrometer is generally equipped with a concentric nebuliser where 
sample solutions are changed into mist, the source used to generate the high temperature 
plasma required to atomise and ionise the analytes, the basic spectrometer which has the 
task of separating the emission lines generated by the sample and a detection system 










The ICP-OES is a powerful instrument used for analysis of a variety of sample matrices 
including environmental, pharmaceutical, industrial and biological samples.   
 
2.4.1.1 Preparation of standard solutions 
 
High purity 1000 mg L
-1
 stock solutions of Cr, Cu, Fe, Zn and Pb were used in order to 
prepare standard solutions necessary to determine the calibration curves.  From the 
stock solutions, a 1 mg L
-1
 working stock standard solution was prepared by transferring 
an aliquot of 0.1 mL of each metal ion solution into a 100 mL volumetric flask and then 
10 mL of conc. HNO3 was added.  The mixture was diluted to volume with double-
distilled water.  Nitric acid was added to mimic the matrix effects of the sample and 
standard solutions.  Further dilutions were made with double-distilled water to give so-
lutions desirable for the construction of calibration curves.   
 
A total of five standard solutions, with different concentrations, were prepared for each 
element.  The concentration ranges were 0.02 - 0.1 mg L
-1
 for Cr, Cu, Pb and 0.01 - 0.1 
mg L
-1
 for Fe and then 0.1 - 0.5 mg L
-1
 for Zn.   
 
Standard solutions of As, Cd, Co and Ni were not prepared.  A rough scan of the sam-
ples could not confirm the presence of these metal ions in any of the samples.  Blank 
solutions were made up with double-distilled water and an appropriate amount of nitric 
acid was included.   
 
2.4.1.2 Sample analysis for heavy metal determination 
 
A Perkin-Elmer Optima 5300 DV ICP-OES was employed to determine concentrations 
of heavy metals present in the skin-lightening creams.  The instrument conditions were: 
generator power, 1000 W; plasma gas flow rate, 12 L min
-1
; nebuliser pressure, 3 bars 




All the digested cream samples were first scanned before preparation of standard solu-




the samples.  Three different analytical wavelengths were preselected for each element; 
then one of these wavelengths, with high intensity, low detection limits and minimal 
impact on the background of an emission line was chosen for further use for quantitative 
analysis.  The wavelength used for each of the metal ions analysed in this project is 
shown in Table 2.2. 
 
Standard solutions and samples were allowed to aspirate for 60 seconds before sampling 
and the instrument was programmed for sampling each solution five times and the aver-
age was recorded.  The calibration data and the corresponding curves obtained from the 
analysis are shown in Appendices C and D. 
 




Arsenic  193.696 
Cadmium  228.802 
Chromium  267.716 
Cobalt 238.892 
Copper  324.752 
Iron  259.939 
Lead  220.353 
Mercury 253.652 
Nickel 231.604 
Zinc  213.857 
 
2.4.2 Cold-vapour atomic absorption spectrometry 
 
Atomic absorption spectrometry is a technique used to determine the concentration of a 
particular metal ion within samples.
123
  Unlike ICP-OES, no plasma and torch are re-
quired for AAS.  However, the AAS technique uses a flame (air/acetylene or nitrous 
oxide) or a graphite furnace to atomise samples.  The sample is atomised in a flame 




electrodeless discharge lamp, is passed.  The amount of light energy absorbed by free 
ground-state atoms is the measure of the concentration of the selected metal.  
For metals, free ground-state atoms do not exist at room temperature, without heating 
the sample to break the bonds linking atoms into molecules.  The only notable exception 
to this is mercury.  Free mercury atoms can exist at room temperature and, therefore, 
mercury can be measured by atomic absorption without a heated sample.  This is so-
called "cold-vapour atomic absorption spectroscopy" (CV-AAS).
124
 
In the cold-vapour technique, mercury is chemically reduced to the free atomic state by 
allowing the sample to react with a strong reducing agent like stannous chloride (SnCl2) 
or sodium borohydride (NaBH4) in a closed reaction system.
108
  The volatile free mercu-
ry is then driven from the reaction flask by bubbling air or an inert gas through the solu-
tion.  Mercury atoms are carried in the gas stream through the tubing connected to a 
quartz cell, which is placed in the light path of the spectrometer.  The CV-AAS tech-
nique is important due to its low detection limits in the single digit part per trillion (ppt) 
range and an abundance of analytical methods which allow for the measurement of 
mercury in almost any sample matrix. 
 
To perform mercury analysis with an atomic absorption spectrometer, a manually-
operated accessory such as the Perkin-Elmer MHS 15 Mercury/Hydride System is re-
quired for vapour generation.  Figure 2.3 depicts the pneumatic system of the MHS 15 
unit.  The MHS 15 unit comprises a reactor assembly (a reaction flask, reservoir bottle 
and carrier gas pipelines) and a quartz tube atomiser (QTA) assembly. The MHS 15 
must be well connected to the gas supply and the spectrometer. 
 
During the analysis of mercury, by using SnCl2 as the reducing agent, the inert gas from 
the pressure reducer flows through restrictor F2 and through line b to the changeover 
valve, and then travels through line e to the reaction flask.  However, the gas pressure 
applied by means of ports 1 to 4 and then via line g, forces the transfer of SnCl2 reduct-
ant solution through line h into the reaction flask.  Mercury vapour is then transported 
by the combined gas streams through the transfer tube f to the QTA, where its atomic 









Figure 2.3 (a) A photograph of the atomic absorption spectrometer.  (b) Schematic representa-





The reduction of mercury to the elemental state by stannous chloride (in acidic solution) 




2𝐻𝑔2+  +  𝑆𝑛2+ +  2𝐶𝑙−  →  𝐻𝑔2𝐶𝑙2   +  𝑆𝑛
4+  
𝐻𝑔2𝐶𝑙2  +  𝑆𝑛
2+  →  2𝐻𝑔 +  𝑆𝑛4+  +  2𝐶𝑙−   
 
2.4.2.1 Preparation of reagents and standard solutions 
 
The reductant solution, 5% SnCl2.2H2O, was prepared by dissolving 50 g of the salt in 
100 mL of hot conc. HCl.  This solution was then diluted to 1 L with distilled water.  To 
prepare a stock solution of 1000 mg L
-1
 mercury, a mass of 0.135 g mercury chloride 
(HgCl2) was accurately weighed and dissolved in 25 mL of distilled water and the solu-
tion was diluted to 100 mL in a volumetric flask with distilled water.  Thereafter, a 1 mg 
L
-1
 mercury working stock standard solution was prepared by pipetting 100 μL from the 
stock solution into a 100 mL volumetric flask and diluted to volume with distilled wa-
ter.  This solution was used to construct the calibration graph.  The dilute nitric acid 
(10% HNO3) solution was also prepared for use during all analyses. 
 
2.4.2.2 Sample analysis for mercury determination 
 
Mercury analysis was carried out with a Perkin-Elmer Analyst 100 atomic absorption 
spectrometer fitted with a hallow cathode lamp operated at a wavelength of 253.7 nm.  
A Perkin-Elmer MHS 15 Mercury/Hydride System was also connected to the instru-
ment.  
 
During analysis, 10 mL of dilute acid (10% HNO3) was placed into the reaction flask, to 
which aliquots of 100, 200, 300, 400, 500, 600 μL of a 1 mg L
-1
 mercury working stock 
solution was added sequentially to generate the calibration standards.  These aliquots 
corresponded to 100, 200, 300, 400, 500, 600 ng of mercury.  When the reaction flask 
was attached to the reactor assembly, the extractor was then switched on and the argon 
gas was also allowed to flow through the immersion tube placed into the reaction flask.  




reaction flask to reduce mercury (either in the standard or sample solution).  The stream 
of inert gas was required to promote mixing of the solutions and to drive out mercury 
vapour through the immersion tube to the QTA.  The reaction flask and the outside of 
the immersion tube were rinsed with dilute acid after every single measurement.  As the 
mercury atoms passed into the QTA, the measured absorbance gradually increased and 
then decreased as the mercury was depleted.  The highest absorbance detected for each 
measurement was recorded.  Absorbance readings for standard solutions were used to 
plot the calibration graph.  Standard solutions were analysed in triplicate and digested 
samples were analysed five times. 
 
2.4.3 Validation of quantitative methods 
 
The suitability of the two methods, ICP-OES and CV-AAS, used to determine the heavy 
metal content in skin-lightening creams was evaluated by determining the instrumental 
limits of detection (LODs) and quantification (LOQs), linearity, precision and accuracy. 
 
Due to the lack of a cream-based certified reference material, the accuracy of the meth-
ods was determined by means of recovery tests.  Therefore, a known amount of each 
element under study was added into a cream that was free from the spike element.  A 
mass of 0.20 g of cream was accurately weighed, transferred into the reaction vessels 
and spiked with the following solutions: 0.05 mg L
-1
 of Cr, 0.045 mg L
-1
 of Cu, 0.025 
mg L
-1
 of Hg and 0.03 mg L
-1
 of Pb; these were added into SLC33 while 0.4 mg L
-1
 of 
Zn and 0.25 mg L
-1
 of Fe were added into SLC4.  Thereafter, 10 mL of conc. HNO3 was 
added to the solutions and allowed to predigest.  The digests were filtered, diluted to a 
volume of 50 mL with double-distilled water and analysed according to the analysis 
conditions of the parent-samples.  The recovery results are reported in Chapter 3, Sec-
tion 3.2.3.  
 
The precision of the methods was expressed as the relative standard deviation (RSD) of 
the measurements.  The limits of  detection  and quantitation (LOQ) for both ICP-OES 
and CV-AAS methods were determined based on the standard deviation amongst re-
sponses and slope of the regression equation of a curve constructed at lower concentra-
tion levels as discussed by Bunhu, 2006.
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squares regression method.  The LOD was calculated as 3Sy/x b
-1
 and the LOQ as 3.33 × 
LOD, where Sy/x is the standard deviation of the slope and b is the slope of the relevant 
calibration line.  The calibration data and graphs as well as the residual plots are shown 
in Appendices C and D. 
 
2.5 Determination of active organic agents by high performance liquid 
chromatography 
 
Chromatography and spectrophotometry are the major techniques described in the lit-
erature for the determination of various lightening agents in cosmetic products.
124-126
  
For instance, a rapid and sensitive reversed-phase high performance liquid chromatog-
raphy (RP-HPLC) method has been developed for the separation of phenol, hydroqui-
none and six preservatives,
130
 as well as phenol, resorcinol, α–hydroxy acids and sali-
cylic acid in creams and lotions.
130
  Furthermore methods for the analysis of arbutin 





 and micellar liquid chromatography.
131
 Desiderio et al.
132
 
quantified hydroquinone and its ethers in cosmetics by capillary electrochromatography.  
Chisvert et al.
135
 also described an uncommon but interesting gas chromatography-mass 
spectrometric method for the simultaneous determination of kojic acid, azelaic acid, 
arbutin, resorcinol and hydroquinone in cosmetic products.  In some cases, UV-visible 
spectrophotometry has been successfully used for the determination of HQ as a single 
active agent.
136-137
 However, the technique is exposed to interferences that can cause 
poor resolution since peaks overlap with an increase in the number of analytes in the 
matrix.
126
  In general, chromatography has been the powerful method for the determina-




Chromatography is a technique by which a mixture is separated into its components.  
This process is based on the distribution equilibrium of the components in a mixture 
between two phases.  The stationary phase which is a solid adsorbent or other packing 
material immobilised in column with special chemical functionality and the mobile 
phase, which transports the mixture through the system.  The mobile phase can be a gas, 
a liquid or a supercritical fluid, hence, the two major separation techniques are gas 
chromatography (GC) and liquid chromatography.
140




widely used, it is limited to compounds that have a significant vapour pressure at 
temperatures up to about 200 ºC.  Thus, compounds of high molecular weight and high 
polarity cannot be separated by gas chromatography unless they are derivatised prior to 
injection.  
As mentioned previously, since the matrix of cosmetic creams contains a variety of 
ingredients that need to be analysed appropriately, liquid chromatography has been a 





 and so was considered as the appropriate technique for 
separating and identifying different compounds in these creams.  It has the advantage 
based on its unique versatility in terms of column and mobile phase interactions or 
mechanisms of separation and selectivity.  HPLC allows one to accomplish very 
difficult separations at low levels of detection, high precision, and accuracy.  The 
following section describes the major components of the HPLC and the principle of 
separation in detail. 
 
2.5.1 Description of instrumentation 
 
The HPLC instrument typically has five main units, which are the mobile phase reser-
voir, pump, column, injector system, and detector.  In addition, the recorder and waste 
units are also needed.  Figure 2.4 shows the major components of a HPLC system.  
 
The mobile phase reservoir holds the solvent that intends to carry the samples into the 
column.  The column is a stainless steel tube which is packed with spherical solid parti-
cles needed to effect the separation.  This packing material is called the stationary phase 
because it is held in place by the column hardware.  An injector system or autosampler 
is able to introduce the sample into the continuously flowing mobile phase stream.  The 
detector is responsible for identifying and generating a signal of each eluted component 






Figure 2.4: Components of an HPLC system. 
(http:// www.waters.com/waters/nav.htm?cid=10048919, Accessed on 8
th
 July, 2014). 
 
Different types of detectors can be used in HPLC depending on the properties of the 
compounds being analysed.  A UV detector or photodiode array detector (PDA), fluo-
rescence detector 
10
 and refractive index detector (RI) are the most available for use in 
HPLC.  A photodiode array detector is commonly used for a wide variety of substances 
that can absorb light within the ultraviolet to visible region (190-900 nm).  The PDA 
makes possible simultaneous monitoring of more than one absorbing component at dif-
ferent wavelengths.  This provides the benefit of time-saving and reduction of solvents.   
 
Other detectors, such as the fluorescence detector (FL), the differential refractive index 
detector (RI), the electrochemical detector (ECD) and the evaporative-light-scattering 
detector (ELSD), are also available to meet different sample requirements.
140
  A mass 
spectrometer is the ultimate detector for liquid chromatography (LC-MS) that signifi-
cantly enhances the application range for HPLC in terms of sensitivity and selectivity.  
This type of detection is based on fragmentation of molecules by electric fields and sep-





The solvent delivery system or pump mainly serves to move the solvent through the 
column with a constant and high-pressure flow.  The pump controls both isocratic and 
gradient flow modes.  In isocratic mode, the composition (polarity) of the mobile phase 
remains constant throughout the run, while a gradient mode can change the proportions 
of solvents during the analysis. 
 
The recorder reads out the information given from the detector.  It interprets and records 
detected compounds by means of peaks and produces chromatograms as relevant.  The 
waste unit serves to carry undesirable solutions given from the detector.  Tubing lines 
and fittings are also necessary for interconnection of the pump, injector, column and 
detector components in order to form an entire channel for the mobile phase, sample, 
and separated compounds.  The following sections give a description of the procedures 
used in the quantitative analysis of the organic active ingredients contained in the skin-
lightening preparations investigated in this study. 
 
2.5.2 Identification of skin-lightening active ingredients 
 
Characterisation of active ingredients in various products was done based on UV spectra 
and the retention time of pure analytes and sample products.  This was achieved by first 
recording spectral information of analytes (active ingredients) by means of UV-visible 
spectrophotometry.  Furthermore, UV-visible spectra of pure analytes, measured by a 
UV-visible spectrophotometer, were compared with those obtained from the PDA de-
tector in HPLC in order to confirm the identity of each compound.  To identify compo-
nents in a particular sample product, only HPLC-UV-visible spectra of the pure analytes 
were compared with those of sample analytes.  On the other hand, the retention times of 
pure analytes and those of sample active ingredients were also verified. 
 
This section presents a brief background information on UV-visible spectrophotometry 
and equipment as well as the spectral information of the various active agents detected 





2.5.2.1 Theory of UV-visible absorption spectrophotometry 
 
UV-visible spectroscopy is routinely used for the qualitative determination of highly 
conjugated organic compounds, biological macromolecules, and transition metal ions.  
Organic compounds absorb light in the UV or visible regions of the electromagnetic 
spectrum.  For a fixed path length, UV-visible spectroscopy can be used to determine 
the concentration of an absorbing species in a solution by using the Beer-Lambert law, 
which states that the absorbance of a solution is directly proportional to the concentra-
tion of the absorbing substances in the solution and the pathlength, which can be written 
symbolically as:  
A = log10(Iₒ I⁄ ) = εcL, 
 
where A is the measured absorbance, Io is the intensity of the incident light at a given 
wavelength, I is the transmitted intensity, L is the pathlength through the sample, c is 
the concentration of the absorbing substance, and ε is the molar absorptivity constant 
that designates a fundamental molecular property of a given substance. 
 
Different substances absorb different wavelengths of light, and this can be used to iden-
tify the presence of particular functional groups in organic compounds. 
 
2.5.2.2 Instrumentation  
 
A UV-visible spectrophotometer consists of three major components: the source, dis-
persive system which is ordinarily integrated in a monochromator, and a detector.  
These components are typically combined in the same instrument to enable chemical 
analysis.  An absorption spectrophotometer measures the way that the light absorbed by 
a compound varies across the UV and visible spectrum.  Figure 2.5 illustrates a sche-
matic representation of a double-beam spectrophotometer.   
 
Two types of light sources, namely, a tungsten halogen lamp and a deuterium lamp, are 
commonly used in this spectral domain.  An incandescent lamp made from a tungsten 




wavelengths longer than 350 nm while a deuterium lamp is needed for the UV portion 
of short wavelengths (< 350 nm).  The sample cell contains a solution of the substance 
needed for test that can be placed in the optical path before or after the monochromator 
and the recorded spectra can be treated by using a number of different computer algo-
rithms.  The detector is usually a photomultiplier tube and the wavelength selector is a 







Figure 2.5: Schematic of a double-beam UV-visible spectrophotometer. 
(http://en.wikipedia.org/wiki/Ultraviolet%E2%80%93visible-spectroscopy, Accessed on 
15
th
 November, 2014). 
 
A double-beam Perkin Elmer Lambda 25 UV-visible spectrophotometer was used to 
measure the maximum absorbance of skin-lightening active ingredients.  Data were rec-
orded and presented in the form of spectra.  The UV-visible absorption spectra of the 






2.5.2.3 Determination of UV absorbance of skin-lightening active agents 
 
The UV absorption bands of lightening agents were obtained over the wavelength range 
of 190 nm to 400 nm, by using 1cm pathlength quartz cuvettes and deionised water as 
the blank in the reference beam.  The maximum absorbance was detected at 246 nm for 
BQ, 222 and 289 nm for HQ, 211 and 270 nm for phenol, 214 and 262 nm for NA, 223 
and 286 nm for ARB, 218 and 269 nm for kojic acid, 242 nm for HCV, and 239 nm for 
CP.  The spectra are shown in Figures 2.6 - 2.13 with the respective concentrations of 
each active ingredient used.  All active ingredients (pure standards) were dissolved in 
water to obtain these spectra.   
 
 
Figure 2.6: UV absorption spectrum of phenol (1.09  10
-3
 M) in deionised water.  The 

























Figure 2.7: UV absorption spectrum of hydroquinone (1.09  10
-3
 M) in deionised water.  
Maximum absorbance for the long wavelength peak was observed at 289 nm. 
 
Figure 2.8: UV absorption spectrum of benzoquinone (1.09  10
-3
 M) in deionised water.  













































Figure 2.9: UV absorption spectrum of arbutin (6.071  10
-4
 M) in deionised water.  
Maximum absorbance for the long wavelength peak was observed at 286 nm. 
 
Figure 2.10: UV absorption spectrum of niacinamide (8.059  10
-4
 M) in deionised 
















































Figure 2.11: UV absorption spectrum of kojic acid (1.531  10
-4
 M) in deionised water.  
Maximum absorbance for the long wavelength peak was observed at 269 nm. 
 
Figure 2.12: UV absorption spectrum of hydrocortisone valerate (1.395  10
-3
 M) in 















































Figure 2.13: UV absorption spectrum of clobetasol propionate (1.395  10
-3
 M) in 
deionised water.  Maximum absorbance for the long wavelength peak was observed at 
239 nm. 
 
2.5.3 Development of high performance liquid chromatography method  
 
Several precautions were taken in the day to day operation of the analytical HPLC 
method in order to consistently obtain the best possible results.  A brief summary is giv-
en below. 
 
All organic solvents were of HPLC-grade, and ultrapure water obtained from a Milli-Q
®
 
unit was used to prepare all solutions.  The mobile phase was prepared daily and filtered 
through Millipore 4.5 μm HV organic aqueous filters for removal of any particulates.  
The mobile phase was degassed with high purity helium at a rate of 100 mL min
-1
 for 5 
minutes prior to use.  The degassing process was to prevent a change in PDA signal-to-
noise ratio caused by light scattering that can be due to air bubbles in the eluents.  The 
required volumes of methanol and water eluents were separately measured out with 
measuring cylinders and premixed to avoid a negative volume of mixing or gas 
























To stabilise the baseline by ensuring that the entire flow system was fully saturated with 
the mobile phase, the HPLC pumps were left on overnight pumping at a rate of 0.1 mL 
min
-1
.  The PDA detector and the column were also allowed to equilibrate for approxi-
mately 30 minutes before injection.  This minimised the problems of pressure fluctua-
tions and noisy baseline which can cause inconsistencies in retention time. 
 
Samples were filtered prior to injection by using Millex HV solvent resistant syringe 
filters to remove any particulate matter.  Blank injections were run in between samples 
to check that the injection port, needle, and column were clean.   
 
In the following sections, the techniques used for optimising the chromatographic con-
dition are discussed in detail.  The separation and extraction of active skin-lightening 
agents was first studied during the development of the HPLC analytical method.  Sec-
tions 2.5.3.1 and 2.5.3.2 describe how these two important factors were investigated.  
The suitability and reproducibility of the quantitative method developed was checked to 
evaluate inconsistencies in the results. 
 
2.5.3.1 Determination of optimum separation method 
 
As mentioned in (Section 2.5), reversed-phase is the most suitable HPLC method for the 
determination of a multi-component mixture of skin-lightening products.  Based on this 
method, chromatographic separations were performed with a Brownlee C18 (4.6 mm × 
100 mm, 5 μm) column.  It is believed that organic molecules have hydrophobic regions 
in their structures and effectively interact with the stationary phase in the reversed-phase 
mode.
9,10
  The mobile phase in reversed-phase chromatography is more polar than the 
stationary phase,
139
 hence, hydrophilic molecules in the mobile phase will tend to elute 
faster than hydrophobic molecules.
9
  Since the mobile phase in reversed phase chroma-
tography contains a polar solvent, separation of the detected whitening agents was car-





By using an isocratic elution mode, several mobile phases were tried including metha-
nol and water (60:40, v/v), methanol and water (50:50, v/v), methanol and water (55:45, 
v/v), methanol and water (45:55, v/v), acetonitrile and water (50:50, v/v), methanol and 
0.2% acetic acid water (45:55, v/v), in order to obtain the best separation of the studied 
active organic ingredients in various commercial lightening creams.  Mixtures of stand-
ard solutions were used for this assay.  The flow rate was alternatively changed from 0.5 
mL min
-1




2.5.3.2 Determination of optimum extraction method 
 
A preliminary extraction test was carried out in order to determine a suitable solvent for 
the extraction of the active ingredients contained in the skin-lightening creams.  The 
extraction method for the sample preparation was studied on five lightening agents and 
the analysis was done by HPLC on a Phenomenex C18 (4.6 mm × 250 mm, 5μm) col-
umn. 
 
About 1.0 g of a cream containing no lightening agents was weighed into a glass flask, 
and small amounts of a mixture containing the same concentration of each of the light-
ening agents: HQ, BQ, PO, ARB and CP, were immediately added and then diluted 
with 10 mL of each extractant (solvent) mentioned below.  This solution was stirred for 
5 min, brought to a total volume of 25 mL, ultrasonicated in a water bath at 40 °C for 20 
min and allowed to cool down before injection.  A 100% methanol, 100%, acetonitrile, 
a mixture of 80% methanol in water, 60% methanol in water, 50% methanol in water 
and a mixture of 45% acetonitrile and 45% methanol in water were used as extractants.  
The ultrasonication parameters used were determined according to a modified method 
reported in the literature.
19
  The method states that a 0.25 g mass of the cream was dis-
solved into 10 mL acetonitrile and the mixture was sonicated in a hot water bath at 40 
°C for 15 min.  In this work, a mass of 1.0 g of the cream sample was dissolved into 10 
mL methanol and the mixture was placed in an ultrasonic bath and held there at 40 °C 





2.5.3.3 Preparation and analysis of standard solutions  
 
A 1000 mg L
-1
 stock solution of each studied analyte was prepared by dissolving 0.025 
g of each standard in 25 mL of methanol.  After adding the solvent to the proper amount 
of the standard in a volumetric flask, the mixture was kept in an ultrasonic bath for 10 
min, to ensure that all solutes were completely solubilised.  Three standard stock solu-
tions for each active ingredient were made and stored at  ̶ 20 °C for a period not longer 
than a week.  A 100 mg L
-1
 standard working stock solution was prepared by diluting 
and mixing aliquots from the stock solutions.  A set of working standard stock solutions 
was prepared.  This included HQ, BQ, PO, ARB, CP, HCV and NA.  From the working 
standard stock solution, serial dilution was performed by using the mobile phase.   
 
Seven different concentrations of standard solutions were prepared from the working 
standard solutions in the range of 1.25 – 25 mg L
-1
 for HQ and PO, 0.625 – 20 mg L
-1
 
for BQ, ARB and NA, 0.391 - 25 mg L
-1
 for CP and HCV.  Aliquots of standard solu-
tions were transferred into vials and subjected to HPLC analysis in order to generate 
calibration curves.  Calibration curves were used for the quantitation of active ingredi-
ents in skin-lightening products. 
 
During the analysis, the autosampler was programmed to perform three injections per 
standard solution, and with blanks injections in between to avoid any carry-over from 
previous injections into the column.  The injection volume was 10 µL and the flow rate 
was at 0.8 mL min
-1
.  The detector was set to monitor the compounds at 240 nm, 270 
nm, and 289 nm. 
 
A Shimadzu Prominence HPLC system (Shimadzu Corporation, Japan) was employed 
to conduct all the analyses. The chromatographic system consisted of: LC-20 AD binary 
pumps, DGU-20A3 degasser, LC-20AD/UFLC XR fraction collector, SIL-20A/UFLC-






2.5.3.4 Preparation of sample solutions and analysis 
 
A mass of 1.0 g of each cream sample was accurately weighed into a 25 mL volumetric 
flask and diluted with 10 mL methanol, then shaken vigorously for 10 min and filled to 
volume with methanol.  After ultrasonication in water bath at 40 °C for 20 min, sample 
extracts were allowed to cool down to room temperature.  All sample solutions were 
filtered through a millipore 0.45 μm syringe filter to remove all particulate matter that 
could clog the column and aliquots were transferred into injection vials for HPLC anal-
ysis.  Three replicates were prepared for each cream sample.  During analysis, the au-
tosampler was programmed so that it performed three injections per sample and sample 
injections were always interspaced with blank injections as was done for the analysis of 
standard solutions.  The results of the quantified skin-lightening products are presented 
in Section 3.3.2.3.   
 
Samples and standard solutions were analysed using Brownlee C18 (4.6 mm × 100 mm) 
column with a mobile phase composed of methanol:water (55:45, v/v).  The flow rate 
was 0.8 mL min
-1
, the wavelengths used were 240, 270 and 289 nm and the maximum 
run time was 12 minutes. 
 
2.5.3.5 Recovery analysis  
 
As a cream-based certified reference material are not available, a sample cream 
(SLC33) containing no whitening ingredients was used as a validation sample in the 
recovery test. This cream was previously screened, in order to check if the spike ana-
lytes were part of its ingredients.  On the assumption that concentration levels of pure 
standard in a validation cream will approximately reach 2.5 and 10 mg L
-1
, two spike 
solutions of different concentrations (62.5 and 250 mg L
-1
) were prepared for each of 
the analytes of interest (HQ, PO, BQ, ARB, NA, CP and HCV).  Spiking was done by 
adding these solutions to sample cream (SLC33).   
 
A mass of 1.0 g of validation sample (SLC33) was accurately weighed into 25 mL vol-




ture was diluted with 10 mL methanol, then shaken vigorously for 10 min and filled to 
volume with methanol.  After ultrasonication process, spiked sample solutions were 
filtered through a Millipore 0.45 μm syringe filter and the aliquots were transferred into 
injection vials for HPLC analysis.  The spiked cream samples were analysed in triplicate 
following the method described in Section 2.5.3.4. 
 
2.5.3.6 Data analysis 
 
The data were evaluated by using the Microsoft Excel add-in package called Analy-
sisToolPak. Calibration curves were determined by means of a simple linear regression 
equation, 𝑦 = 𝑎 + 𝑏𝑥, with null intercept,125 where y is the peak area, x is the concentra-
tion of analyte, b is the slope, and a is the intercept.  Assuming that a = 0 at 95% confi-
dence interval, only b needs to be determined to establish the calibration line taking into 
account the error in each of y0, a and b, and thereby to produce an estimated standard 
deviation Sx0 for the point estimate x0 = (y0-a)/b. 
 
The limit of detection was calculated as thrice the standard deviation of the calculated 
values for the lowest concentration of each analyte.  Thus, LOD was calculated as 3Sy/x 
b
-1
(Sy/x is the standard deviation of the slope and b is the slope of the calibration line) 




The percentage of the analyte in the product was determined by using the formula 
% =
𝐶𝑠 × 𝑉𝑠  × D𝑓  × S𝑝
W𝑠
 
where Cs is the concentration of the component of interest from the standard curve 
(mg/ml), Vs is the volume of the sample extract, Df is the dilution factor (where appli-







RESULTS AND DISCUSSION 
 
This chapter discusses the data obtained from the experimental techniques used during 
the course of the investigation as detailed in Chapter 2.  It consists of two major parts, 
described below:  
The first part considers the results obtained from the investigation of the heavy metal 
content of 49 skin-lightening creams.  This was achieved by means of the spectroscopic 
techniques, ICP-OES and CV-AAS.  The second part discusses the chromatographic 
(HPLC) and UV/Vis spectrophotometry results obtained for the qualitative and quantita-
tive determination of the active ingredients of 19 skin-lightening creams. 
 
3.1 Extraction of heavy metals in skin-lightening creams 
 
In order to solubilise the heavy metals in the samples, different extraction techniques as 
described in Sections 2.3.1 and 2.3.2 were evaluated. 
 
3.1.1 Open acid digestion 
 
The extraction of heavy metals in the skin-lightening creams presented a number of 
challenges during the sample pretreatment process. As can be seen in the preliminary 
experiments detailed in Section 2.3.1, the dry-ash process of each tested cream sample 
resulted in approximately 0.18 g (32%) of ash.  This meant that 64% of the constituents 
of the cream sample were decomposed.  The lost part of the sample was linked to the 
presence of organic substances and/or some metals, such as mercury and others which 
are volatile at low temperature.  On the other hand, the acid digestion carried out on a 
hot plate failed to reach a very high temperature and generated a final sample solution 
containing residual materials in the shape of gums and powders which could cause 




lution of the sample matrix.  Besides, these two methods were time-consuming and in-
volved tedious experimental work.  Therefore, the digestion of samples was attempted 
via microwave-assisted digestion.  
 
3.1.2 Microwave-assisted sample digestion 
 
Since the cream samples were not conveniently processed by dry-ashing and wet diges-
tion, they were then irradiated in closed vessels with acid-assisted microwave digestion.  
This method provided a complete break-down and better solubilisation of the organic 
materials for all samples within a short period of time.  However, microwave digestion 
can pose a high risk of explosions.   
 
This was observed when the method used by Na-Ri Cha et al.
119
 for microwave diges-
tion of different cosmetics with a combination of H2SO4 and HNO3 acids were used.  
Also, when a combination of HNO3 and HCl/HF acids was used for digestion of the 
skin-lightening creams in the present study, the vessels exploded at temperatures below 
150 °C.  However, with nitric acid alone, samples were able to reach a maximum tem-
perature of 201 °C without risk of explosions. 
 
The temperature attained in a closed system promoted a fast decomposition of oils, sur-
factants, oxide species, and metallic solid particles of the analytes into their elemental 
forms without sample loss and contamination.  Overall, digest solutions were quite clear 
despite the presence of residual materials found in a few samples in the form of powder 
or suspensions, which could be removed by filtration.  The clear digested solutions ob-
tained showed the successful solubilisation of sample matrices. 
 
Indeed, microwave-assisted nitric acid digestion resulted in reasonable recoveries dur-
ing the extraction of heavy metals in skin-lightening creams in this study.  The recovery 
data are shown in Table 3.3.  To achieve successful mineralisation of cosmetics by mi-






3.2 Determination of mercury and heavy metals in skin-lightening creams 
 
Levels of mercury and other heavy metals in skin-lightening creams were determined by 
using a Perkin-Elmer MHS 15 mercury hydride system and a Perkin-Elmer Optima 
5300 DV ICP-OES respectively.  The ICP-OES and CV-AAS were simple and accurate 
methods for quantifying heavy metals in samples, however, the methods encountered 
challenges, such as interferences, which typically occur for elemental analysis with ICP-
OES.   
 
3.2.1 Linearity of calibration curves for heavy metal analysis  
 
Calibration graphs were obtained by using an external standard calibration method.  For 
each standard solution, three replicates were prepared and measured in the same way to 
generate three data points.  A detailed description of the standards preparation proce-
dure is given in Section 2.4.1.1.  Calibration graphs were constructed from the data ob-
tained for each standard solution.  The calibration data can be found in Tables C1-1 to 
C1-6 of Appendix C and the calibration graphs and residuals plots are shown in Figures 
D1 to D12 of Appendix D.  
 
An analysis of the residuals in the regression showed that they were randomly dispersed 
around the horizontal axis; hence, a good fit for a linear regression model.  These were 
performed by using the Analysis ToolPak package of Microsoft Excel.  The values of 
the linear regression analysis are shown in Table 3.1. 
 
The slope and standard error of the calibration lines for each metal were used to calcu-
late the limit of detection and the limit of quantitation (LOQ).
130
  The LOD was calcu-
lated as 3Sy/x b
-1
 and the LOQ as 3.33 × LOD, where Sy/x is the standard deviation of the 
slope and b is the slope of the calibration line.  The correlation coefficients for all the 
calibration graphs used in the quantitation of Cr, Cu, Fe, Pb, and Zn were not less than 
0.995 (R
2
 > 0.995); the method had limits of detection less than 0.06 mg L
-1
 and limits 
of quantification less than 0.17 mg L
−1






Table 3.1: Linear regression of calibration data for heavy metals. 
 










 8.363 32.823 5.726 7.38 4.107 
Standard error of slope/10
3
 0.666 1.587 0.169 0.123 0.202 
















 7.96 4.83 2.94 1.67 4.92 
- LOD calculated as 3Sy/x b
-1
(Sy/x is the standard deviation of the slope and b is the slope 








3.2.2 Linearity of calibration curves for mercury analysis 
 
A typical regression line between the absorbance signal and the mercury concentration 
was described by the equation: A = 8.093  10
-4
 C Hg (ng) with a coefficient of determi-
nation of 0.996.  The LOD was less than 0.025 ng and the LOQ was less than 0.08 ng.  
Table 3.2 displays the results of the linear regression analysis for mercury. 
 
Table 3.2: Linear regression of calibration data for the analysis of mercury. 
 
Parameters Value 
Calibration range/ng 100-600 
Slope (b)/10
-4
 ng 8.093 
Standard error of slope/10
-6
 6.272 





 ng 2.32 
LOQ/10
-2
 ng 7.74 
- LOD was calculated as 3Sy/x b
-1
(Sy/x is the standard deviation of the slope and b is the 







3.2.3 Validation of quantitation methods 
 
Due to the lack of a cream-based certified reference material, the accuracy of the meth-
ods used for quantitation of metals was checked throughout by performing recovery 
tests.  Test was carried out by spiking skin-lightening samples with known amounts of 
the element of interest as described in Section 2.4.3.  The amounts added and the result-
ing recoveries are reported in Table 3.3.  
 
The mean percentage recoveries achieved ranged from 97.6 % to 106.19 % for all the 
elements analysed.  The RSD values for recoveries were below 3.0% for Cr, Fe, Hg, Pb 
and Zn, while Cu had a value not higher than 7.17%.  Accordingly, the recovery tests 
confirmed that the matrices of the cream samples were consistently mineralised. 
 

















Cr 12.374 12.561 101.57 0.27 2.11 
Cu 11.133 11.014 98.97 0.79 7.17 
Fe 61.597 60.12 97.6 0.17 0.28 
Hg 6.024 6.363 105.61 0.18 2.87 
Pb 7.207 7.653 106.19 0.16 2.05 
Zn 95.507 96.921 101.51 2.01 2.07 
 
3.2.4 Levels of mercury and heavy metals in selected skin-lightening creams  
 
This study investigated the level of ten heavy metals (As, Cd, Co, Cr, Cu, Fe, Hg, Ni, 
Pb and Zn) in 49 skin-lightening creams sold in South Africa.  The results showed that 
six metals (Cr, Cu, Fe, Hg, Pb and Zn) could be detected.   
 
Table 3.4 shows the distribution of heavy metals in the studied samples.  As seen, arse-
nic, cadmium, cobalt and nickel were undetectable in all the skin-lighteners while cop-
per was detected in all samples with concentrations varying from 0.19 to 8.93 μg g-1.  




tion was found in sample SLC27.  Copper compounds and CuO nanoparticles  are used 





 reported that several commercial cosmetic products are based on copper–peptides 
that have been proven to calm irritated skin, improve skin elasticity and firmness, repair 
photo-damaged skin and reduce facial wrinkles.  These could be responsible for the 
presence of copper in this study.  However, topically applied CuO nanoparticles have 





Chromium was detected in eight products and lead was present only in three products.  
The concentrations of Cr and Pb ranged from 1.73 to 12.56 μg g-1 and 2.98 to 15.72 μg 
g
-1
, respectively.  The product SLC4, which contained a high content of Cr, also had the 
highest level of Pb that is above the WHO and Canadian Health’s acceptable limits.  
Table 3.4 shows a comparison of the toxic metal levels detected in certain skin-
lightening creams investigated with some permissible standards for cosmetics.  
 
Iron was found in 33 samples (i.e. 67.3% of the samples that were tested).  The iron 
concentrations varied from 0.55 to 25007 μg g-1, most samples having contents between 
3.48 and 46.26 μg g-1.  Remarkably, higher concentrations of 3860.9 μg g-1 (0.39% 
m/m), 5666.6 μg g-1 (0.57% m/m) and 25007 μg g-1 (2.5% m/m) were obtained in 
SLC17, SLC39 and SLC31, respectively.  High levels of Fe (6.15%) were also reported 
in local eye shadows sold in Nigeria,
39
 although, Ullah et al.
110
 found Fe (0.25%) in 
cosmetic creams manufactured in Pakistan.  Iron oxide has been used in colour cosmet-
ics to mask minor imperfections of the skin.  Keeping in view of its function in the hu-
man body, there is no significant health hazard reported on the topical application of 
iron and iron compounds.
39, 105
  In contrast, the essential metals are toxic when present 




Zinc was detected in less than five products and the concentrations found ranged from 
79.97 to 12470 μg g-1 which corresponds to the range of 0.008 to 1.2% (m/m).  Zinc 
salts and compounds have been approved by the FDA for over-the-counter (OTC) uses 




screens approved to reduce skin penetration by UVB radiation and provide protection 
against UVA radiation.
105
  The European laws banned cosmetic formulations containing 
more than 0.5% zinc pyrithione while other zinc salts are allowed up to 1% (calculated 
as zinc) in cosmetics.
42
   
 
Table 3.4: Comparison of toxic metal levels with some permissible standards for cos-
metics. 
 
























SLC1 - - 3.73 - - - 
SLC2 - - 2.29 - - 2.98 
SLC4 - - 12.56 - - 15.72 
SLC12 - - - 2.49 - - 
SLC17 - - - - - 9.15 
SLC27  - - 4.41 - - - 
SLC36 - - 7.72 - - - 
SLC39 - - 1.73 2.94 - - 
SLC43 - - - 7.57 - - 
SLC45 - - - 51.19 - - 
SLC46  - - 10.71 - - - 
SLC47  - - 4.73 - - - 
Health Canada
150
  3.0 3.0  3.0  10.0 
WHO
18,45
 10.0 0.3  1.0  10.0 
*banned in cosmetics by FDA
41
 
WHO (World Health Organization) 
- Not detected 
 
The concentration of zinc (1.2% m/m) in sample, SLC45, was above the acceptable lim-
it.  In addition, the mercury content in this product exceeded the permissible limit estab-
lished by the WHO (< 1.0 ppm),
18
 and the Health Canada limit (3.0 ppm).
150
  Countries 
and international organisations have regulated toxic metals for cosmetic use.   
 
Mercury was detected in four products: SLC12, SLC39, SLC 43, and SLC45 with levels 
of 2.49, 2.94, 7.57, and 51.19 μg g-1 respectively.  Higher concentrations of mercury in 
some cosmetic creams have been reported.  For instance, Al-Saleh et al.
18
 has found 




extremely high mercury content of 878 and 36000 μg g-1 in Mexican facial whitening 
creams.  Mercury, through skin absorption, can enter and accumulate in body tissues 
and attack the brain, immune system, kidneys and the ovaries.  This can cause psycho-
logical, neurological, immunological and other problems in humans.
20
  Engler et al.
151
 
reported that application of skin-lightening creams containing mercury during pregnan-




Table 3.5: Levels of heavy metals detected in different samples of skin-lightening creams analysed in this study (n = 3).  (SLC-Skin-
lightening cream, LOD-Limit of detection, - Not detected) 
 
Sample Code 
Mean concentration ± SD/μg g-1 
Cr Cu Fe Hg Ni Pb Zn 
SLC1 3.73 ± 0.10 2.13 ± 0.06 - - <LOD <LOD - 
SLC2 2.30 ± 0.11 2.79 ± 0.01 39.22 ± 1.73 - - 2.98 ± 0.16 <LOD 
SLC3 <LOD 1.70 ± 0.14 3.93 ± 0.10 - <LOD <LOD <LOD 
SLC4 12.56 ± 0.07 2.71 ± 0.15 8.45 ± 0.43 - - 15.72 ± 0.72 - 
SLC5 - 0.93 ± 0.05 - - - <LOD <LOD 
SLC6 <LOD 5.38 ± 0.51 7.94 ± 0.45 - - <LOD <LOD 
SLC7 <LOD 5.92 ± 0.51 - - - <LOD - 
SLC8 - 2.24 ± 0.16 7.53 ± 0.39 - - <LOD <LOD 
SLC9 <LOD 0.57 ± 0.04 46.26 ± 4.18 - - <LOD - 
SLC10 <LOD 6.68 ± 0.15 22.19 ± 1.03 - - - <LOD 
SLC11 <LOD 8.93 ± 0.56 4.25 ± 0.27 2.49 ± 1.21 - <LOD <LOD 
SLC12 - 1.40 ± 0.16 1.58 ± 0.12 - <LOD <LOD <LOD 
SLC13 <LOD 4.61 ± 0.24 - - - <LOD <LOD 
SLC14 - 0.93 ± 0.08 7.94 ± 0.52 - - <LOD <LOD 
SLC15 <LOD 2.18 ± 0.15 9.60 ± 0.18 - - <LOD <LOD 
SLC16 <LOD 1.80 ± 0.14 25.07 ± 1.24 - - <LOD <LOD 
SLC17 <LOD 2.88 ± 0.23 3861. ± 228.8 - <LOD 9.15 ± 0.07 <LOD 
SLC18 - 2.34 ± 0.01 - - - <LOD <LOD 
SLC19 <LOD 0.97 ± 0.08 16.36 ± 1.13 - <LOD <LOD <LOD 
SLC20 <LOD 4.70 ± 0.34 3.48 ± 0.30 - - <LOD <LOD 
SLC21 <LOD 6.07 ± 0.17 90.93 ± 2.12 - - <LOD <LOD 





Mean concentration ± SD/μg g-1 
 
Cr Cu Fe Hg Ni Pb Zn 
SLC23 <LOD 1.10 ± 0.08 - - - <LOD <LOD 
SLC24 <LOD 1.56 ± 0.02 - - - <LOD <LOD 
SLC25 <LOD 1.76 ± 0.02 2.60 ± 0.15 - - <LOD <LOD 
SLC26 <LOD 1.74 ± 0.05 12.95 ± 0.42 - - <LOD - 
SLC27 4.41 ± 0.03 0.19 ± 0.02 45.84 ± 2.94 - - <LOD <LOD 
SLC28 - 2.67 ± 0.13 10.19 ± 0.23 - - <LOD <LOD 
SLC29 - 3.62 ±0.29 10.48 ± 0.72 - - <LOD <LOD 
SLC30 <LOD 2.70 ± 0.13 7.024 ± 0.39 - - <LOD <LOD 
SLC31 <LOD 0.97 ± 0.13 25007±906.6 - <LOD <LOD <LOD 
SLC32 <LOD 0.28 ± 0.25 56.32 ± 0.71 - <LOD <LOD <LOD 
SLC33 - 1.64 ± 0.02 - - - N.D. - 
SLC34 - 1.54 ± 0.16 - - - <LOD <LOD 
SLC35 <LOD 1.94 ± 0.16 - - - <LOD <LOD 
SLC36 7.73 ± 0.10 5.40 ± 0.11 - - - <LOD - 
SLC37 <LOD 1.27 ± 0.06 - - - <LOD <LOD 
SLC38 - 2.71 ± 0.31 - - - <LOD <LOD 
SLC39 1.74 ± 0.10 4.79 ± 0.25 5666. ± 11.85 2.94 ± 1.58 - <LOD <LOD 
SLC40 - 2.85 ± 0.30 112.1 ± 5.34 - - <LOD <LOD 
SLC41 <LOD 1.13 ± 0.02 - - - <LOD 79.97 ± 4.14 
SLC42 <LOD 1.06 ± 0.06 0.55 ± 0.04 - <LOD <LOD 7148. ±154.1 
SLC43 <LOD 2.66 ± 0.12 9.76 ± 0.84 7.58 ± 1.80 - <LOD <LOD 
SLC44 - 2.12 ± 0.29 - - - <LOD <LOD 
SLC45 <LOD 3.56 ± 0.66 61.06 ± 4.88 51.19 ± 12.25 - <LOD 12470 ± 420 
SLC46 10.71 ± 0.09 1.65 ± 0.11 3.60 ± 0.38 - - <LOD - 
SLC47 4.73 ± 0.01 3.47 ± 0.02 11.83 ± 0.63 - - <LOD <LOD 
SLC48 <LOD 3.26 ± 0.11 10.80 ± 0.27 - - <LOD <LOD 




3.3 Determination of skin-lightening organic active ingredients 
 
It was desirable to first develop a method that defines the chromatographic conditions 
suitable for characterisation and separation of lightening active ingredients quantifica-
tion.  The following sections discuss in detail the results of the experiments conducted 
for determining the organic active ingredients contained in the skin-lightening creams 
chosen for this study. 
 
3.3.1 Method development and optimisation of chromatographic conditions 
 
The optimisation and validation of the instrumental conditions were performed by using 
an HPLC system (Shimadzu Prominence) consisting of a binary solvent manager, au-
tosampler and photodiode array detector.  The output signal was monitored and pro-
cessed by using Shimadzu LCsolution software.  Chromatography and resolution of 
skin-lightening active ingredients was performed on a Brownlee C18 4.6 mm × 100 
mm, 5.0 μm column with an isocratic elution method.   
 
3.3.1.1 Determination of optimum wavelength for UV detector 
 
A detection wavelength which provides high sensitivity and better resolution of analytes 
was used for the determination of detected agents.  The UV spectra and the maximum 
absorption peak of each studied lightening active agent were first obtained by means of 
a UV-visible spectrophotometer.  The representative spectra were given in Chapter 2, 
Figures 2.6-2.13.  The maximum UV absorbance is at 246 nm for BQ, at 242 nm for 
HCV, 289 nm for HQ, at 239 nm for CP, at 270 nm for phenol, at 262 nm for NA, at 
269 for KA and at 286 nm for ARB.  Standard solutions were prepared in deionised 
water.  These UV spectra and the maximum absorbance for the long wavelength peak 
were used to confirm the UV spectra generated by the PDA detector in HPLC.  Figure 
3.1 confirms the identity of the UV absorbance of the detected active ingredients ob-



























Figure 3.1: Comparison between PDA-HPLC UV spectra (left) vs UV-Vis 













































































































































































The UV detector showed a high sensitivity in detecting PO, KA and NA at 270 nm, HQ 
and ARB at 289 nm, and BQ, CP, and HCV at 240 nm.  At 270 nm, clear peaks for all 
compounds in the HPLC-chromatograms were observed; however, but the highest 
sensitivity was noticed only for PO, KA and NA.  Therefore, in order to improve the 
quantitation of these ingredients, three UV absorption wavelengths (240, 270, and 289 
nm) were considered during the analysis of both standards and samples.  
 
In order to identify skin-lightening organic active ingredients: HPLC-UV-visible spectra 
and the retention time’s representative for the pure analytes and those for detected 
analytes in sample product were considered 
 
3.3.1.2 Identification of active ingredient in skin-lightening product 
 
To identify components in a particular sample product, only HPLC-UV-visible spectra 
of the pure analytes were compared with those of sample analytes.  Furthermore, the 
retention times of pure analytes and those corresponding to their related compound in 
sample active ingredients were also verified.  Table 3.6 indicates the variability of the 
retention times for each active ingredient quantified in skin-lightening creams. 
 
Table 3.6: Variability in retention time of detected active ingredients (n = 9). 












KA was removed from the standard mixture.because it consistently produced a peak 
that tailed thereby affecting the resolution of other compounds.  Consequently, a 
standard solution containing KA only was used to characterise this agent.  The retention 
time of KA was 1.46 min.  Figure 3.2 shows the chromatogram for the elution of KA. 
 
 
Figure 3.2: HPLC chromatogram of KA standard solution (2.5 mg L
-1
).  The retention 
time is at 1.46133 minutes.  The detection wavelength was 270 nm. 
 
3.3.1.3 Determination of optimum separation of the skin-lightening agents 
 
Most of the skin-lightening active ingredients are very polar molecules.  For polar ana-
lytes, a polar solvent, such as water, methanol or acetonitrile, is usually used as a con-
stituent of the mobile phase for a HPLC separation effected on a C18 column.  Howev-
er, the co-elution of these polar analytes is a challenge for their simultaneous analysis. 
 
It is well-known that a good separation condition should satisfy the need that the ana-




Therefore, to obtain the chromatograms with the good separation, mobile phases with 
different compositions of methanol in water, detection wavelengths and flow rates vary-
ing between 0.5-1.2 mL min
-1
 were investigated. 
 
When a mobile phase consisting of 60% methanol, and above, in water was used at a 
flow rate of 0.8, 1 and 1.2 mL min
-1
 peaks either co-eluted or clustered together, while 
at 0.5 mL min
-1
 peaks broadened.  In the reverse, when 40% methanol and below was 
used, only CP and HCV could be separated from the other components and the retention 
times were also increased with the reduction of the methanol percentage in the mobile 
phase.   
 
On the other hand, elution time of the components was decreased as the polarity of the 
mobile phase was decreased by adding more organic solvent (methanol).  Actually de-
creasing the mobile phase polarity reduces the hydrophobic interaction between the so-
lute and stationary phase resulting in desorption.  This implies also that the more hydro-
phobic the molecule the more time it will spend on the stationary phase in RP-HPLC. 
 
By using mobile phases of 45% methanol, 50% methanol, and 50% acetonitrile in wa-
ter, the resolution of the peaks was better at 0.8 mL min
-1
. However, HQ and NA were 
poorly separated, while late eluting components had broadened peak shapes.  When 
acetic acid was added to these eluents in order to keep acidic groups in the analytes pro-
tonated and thereby improve the peak shapes, similar results were found and the time 
for the analysis was still long. 
 
Finally, the seven ingredients were successfully separated by using a composition of 
55% methanol and 45% water as the mobile phase.  The flow rate was suitable at 0.8 
mL min
-1
 and the total run time was within 10 min.  In addition, the column temperature 
was kept at 25 °C.  Chromatograms in Figure 3.3 show the separation of the active ingredi-

















Figure 3.3: Chromatograms for separation of active ingredients: HQ, BQ, PO, ARB, NA, 
HCV and CP.  Chromatogram (A) shows the separation of BQ, HCV, and CP detected 
at 240 nm, chromatogram (B) shows the separation of NA, PO, HCV, and CP detected 
at 270 nm and chromatogram (C) indicates the separation of ARB and HQ detected at 
289 nm.  The chromatographic conditions used were: Brownlee C18 column, mobile 




3.3.1.4 Determination of extraction solvent and sample preparation 
 
In order to obtain quantitative extraction of the active ingredients from the cream sam-
ples, variables involved in the procedure such as solvent, extraction method and extrac-
tion time were optimized.   
The extraction solvent was optimized for sample preparation by using different solvents 
including acetonitrile, methanol, 80% methanol, 60% methanol, 50% methanol and a 





Peak area and peak height can directly reflect the extraction efficiency of the studied 
components.  The results showed that with the increase of methanol content, the peak 
areas of the components increased and peak height also showed a slight increase.  It has 
been reported in the literature
152,153
 that clobetasol propionate and other steroids can be 





When acetonitrile was used as the extraction solvent, the peak areas and peak height did 
not change significantly compared with those observed with methanol.  However, the 
peak areas and peak heights were obviously reduced when using the mixture of acetoni-
trile, methanol and water.  From the extraction efficiency of the different solvents (see 
Figure 3.4), it is clear that, when 100% methanol was used, the peak areas of the com-
ponents reached the highest values.  Therefore, after comparing the influence of each 
solvent, pure methanol was selected as the most suitable extraction solvent.   
 
 
Figure 3.4 Effect of different solvents on the extraction of HQ, BQ, PO, ARB, and CP.  a) 
methanol:water (80:20, v/v), b) methanol:water (60:40, v/v), c) methanol:water (50:50, 
v/v), d) acetonitrile:methanol:water (45:45:10, v/v), e) methanol (100%), f) acetonitrile 
(100%). 
 
The extraction was better when the samples were extracted with 25 mL methanol for a 
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cream samples were extracted in methanol and gave acceptable recoveries despite the 
presence of some preservatives (methyl paraben and propyl paraben) which could likely 
interfere with the active ingredients.  Methyl and propyl parabens were detected in most 
samples. 
 
3.3.2 Validation of HPLC analytical method 
 
The characteristics for consideration during validation of the analytical procedures have 
been discussed.
138
  For the validation of the HPLC quantitation method employed in the 
determination of organic active ingredients in different skin-lightening samples, lineari-
ty, accuracy, precision, and the detection limit were evaluated. 
 
3.3.2.1 Linearity of calibration curves and limits of detection 
 
The linearity was assessed based on calibration curves obtained with an external stand-
ard method.  For each curve, three injections were performed for each concentration.  
Seven different concentrations were prepared for each ingredient. The calibration curves 
were determined in triplicate.  Furthermore, regression equations were used for quanti-
tation of the seven whitening ingredients in the cream samples.  Calibration data used to 
construct the calibration curves are given in Tables C2-1 to C2-8 of Appendix C while 
their corresponding calibration curves as well as the residual plots are listed in Figures 
D13- D29 of Appendix D.   
 
The calibration curves were constructed by plotting the peak area against the concentra-
tion.  Linear regression analysis (at 95% confidence level) of the calibration data for 
each active ingredient was performed by using the Microsoft Excel add-in package 
called Analysis ToolPak.  The linearity was confirmed from the correlation coefficient 
R
2
 values.  As shown in Table 3.7, in all cases, peak areas and analyte concentrations 
were found to be linearly related with a correlation coefficient greater than 0.997 (R
2
 > 
0.997) over the range tested for each of the analysed whitening ingredients.  The LOD 
values found in this study were in the range of 0.001 - 0.0065 mg L
-1
 and the LOQ val-






Table 3.7: Results of linear regression analysis of calibration curves for skin-lightening active ingredients analysed by HPLC. 
Parameters HQ BQ PO ARB NA CP HCV 
Maximum absorption/nm 291 246 273 286 262 239 246 
Detection wavelength used/nm 289 240 270 289 270 240 240 
Calibration range/mg L
-1





 1.2072 7.053 1.055 3.090 1.408 2.350 2.484 





















3.3.2.2 Accuracy  
 
The accuracy of the quantitation method was checked by a recovery test.  The results 
are summarised in Table 3.8.  Known amounts of the pure active ingredients were added 
to a cream that did not contain any of these lightening ingredients and analysed in tripli-
cate.  Concentration of each ingredient was subsequently calculated by using the corre-
sponding regression equation of the calibration curve.  The resulting recoveries ranged 
from 87.4 to 105.04 % and the relative standard deviation (R.S.D) values obtained 
ranged from 0.45 to 4.82 %.  No interference was observed at either low or high con-
centrations.  However, the mean percentage recovery achieved for HQ was below 90%.  
Since hydroquinone is easily oxidised into benzoquinone, this could possibly explain 
the low recovery obtained. 
 
Table 3.8: Recoveries of the seven skin-lightening active ingredients (n = 3). 
 







 Recovery/% R.S.D./% 
HQ 2.5 2.26 ± 0.06 90.47 2.60 
 
10 8.71 ± 0.26 87.14 2.98 
BQ 2.5 2.46 ± 0.07 98.25 2.80 
 
10 10.10 ± 0.20 101.02 1.94 
PO 2.5 2.43 ± 0.02 97.35 0.63 
 
10 10.09 ± 0.05 100.88 0.45 
NIA 2.5 2.45 ± 0.09 97.81 1.62 
 
10 9.66 ± 0.07 96.62 0.73 
ARB 2.5 2.63 ± 0.07 105.04 2.77 
 
10 9.86 ± 0.15 98.58 1.54 
CP 2.5 2.40 ± 0.2 95.94 0.99 
 
10 9.37 ± 0.45 93.71 4.82 
HC V 2.5 2.45 ± 0.07 98.15 2.96 
  10 9.69 ± 0.16 96.93 0.93 





3.3.2.3 Precision  
 
The precision of the method was calculated as the relative standard deviation (R.S.D.) 
of assays containing the seven skin-lightening active ingredients in different ranges of 
concentration (low, medium and high).  The authentic standard solutions were prepared 
and subjected to HPLC analysis for assessing the intra-day and inter-day variability.  
The quantity of each analyte was obtained from the corresponding calibration curve.  
The intra-day variability was examined within one day by five replicate injections and 
the results showed that the R.S.D. was in the range of 0.038–1.86 %.  The inter-day pre-
cision was calculated from nine determinations over three consecutive days for each 
concentration.  The R.S.D. values ranged from 0.60 to 2.83 % for inter-day variability 
(see Table 3.9).  For both the intra- and inter-day studies the accuracy was at acceptable 
levels and ranged between 91.8-102.8%. 
3.3.3 The contents of organic active ingredients in skin-lightening creams  
 
The developed method was applied to different skin-lightening products for the 
determination of active ingredients such as NA, HQ, BQ, ARB, PO, CP, and HCV.  The 
list of ingredients contained in each product is shown in Table 2.1.  Table 3.10 shows 
the results of the mean percentage concentrations (% m/m) of different active 
ingredients detected in the skin-lightening creams in this work. 
 
The results of this study showed that out of the nineteen samples analysed, twelve 
creams contain at least one of these seven agents.  The peak areas obtained for the ac-
tive ingredients are given in Appendix F and the representative HPLC chromatograms 
of each cream sample are shown in Figures E5-E16 of Appendix E. 
Three creams contained NA.  The mean concentrations recorded were 0.25, 1.17 and 
1.04% (m/m), for SLC20, SLC21 and SLC31, respectively.  For medical purposes, NA 
is used to treat pustular acne and it can be used up to 5%.
154
  A cream, SLC54, con-
tained 0.94% (m/m) of HQ and 0.008 % (m/m) of BQ.  BQ was also detected in cream 
sample, SLC51.  The content of HQ in this cream is below the maximum limit concen-
tration (2%, m/m) permitted by the World Health Organization 
44















Intra-day (n = 5) 
 
Inter-day (n = 9) 
Found R.S.D./% Accuracy/% Found R.S.D./% Accuracy/% 
HQ 1.45-1.46 2.0 1.89 ± 0.02 1.30 94.5 
 
1.84 ± 0.05 2.50 91.8 
  
6.0 5.92 ± 0.11 1.86 98.7 
 
5.75 ± 0.08 1.40 95.8 
  
24.0 23.85 ± 0.16 0.71 95.2 
 
22.5 ± 0.36 1.58 93.7 
BQ 1.73-1.74 2.0 2.04 ± 0.07 0.94 101.9 
 
1.96 ± 0.05 2.81 97.8 
  
6.0 5.91 ± 0.03 0.58 98.5 
 
5.88 ± 0.05 0.89 97.9 
  
18.0 18.02 ± 0.06 0.32 100.1 
 
17.79 ± 0.31 1.73 98.8 
PO 2.45-2.49 2.0 1.99 ± 0.05 0.90 99.8 
 
1.98 ± 0.01 0.60 99.2 
  
6.0 6.17 ± 0.06 0.87 102.8 
 
6.2 ± 0.08 1.37 100.4 
  
24.0 24.26 ± 0.01 0.038 101.1 
 
23.91 ± 0.29 1.71 99.6 
ARB 1.28-1.33 2.0 2.05 ± 0.01 0.35 102.4 
 
1.98 ± 0.06 2.83 98.4 
  
6.0 5.87 ± 0.03 0.51 97.9 
 
6.02 ± 0.07 1.30 96.5 
  
18.0 17.78 ± 0.12 0.67 98.7 
 
23.91 ± 0.12 0.66 99.6 
NA 1.39-1.43 1.5 1.41 ± 0.01 0.49 94.0 
 
1.40 ± 0.03 2.50 93.4 
  
5.0 4.63 ± 0.039 0.94 92.6 
 
4.65 ± 0.06 1.39 92.9 
  
15.0 14.64 ± 0.07 0.45 97.6 
 
14.43 ± 0.15 1.04 96.2 
CP 8.22-8.30 0.5 0.47 ± 0.05 0.49 94.4 
 
0.47 ± 0.01 1.40 93.8 
  
5.0 4.84 ± 0.04 0.94 96.8 
 
4.85 ± 0.04 0.81 97.0 
  
20.0 19.76 ± 0.04 0.45 98.8 
 
19.66 ± 0.18 0.92 98.3 
HC V 5.0-5.3 0.5 0.48 ± 0.04 1.10 96.6 
 
0.48 ± 0.01 1.08 95.1 
  
5.0 4.78 ± 0.02 0.81 95.7 
 
4.76 ± 0.05 1.04 95.2 
  
20.0 19.39 ± 0.04 0.19 96.9 
 
19.52 ± 0.13 0.67 97.6 
Accuracy (%) = (mean of found concentration/theoretical amount) × 100 




For dermatological therapy hydroquinone is an important agent for treating hyperpig-
mentation.  The use of HQ in cosmetics has been banned by many countries due to its 
toxicity.  A report has revealed that HQ, benzene and/or benzene-ring related molecules, 
for example BQ and PO, may induce marrow toxicity and carcinogenesis.
155
  The risks 
of long-term effects of topical application induce brown discoloration of the skin and 
fingernails, an asymptomatic hyperpigmentation of the face with gradually progressive 
blue-black macular patches and exogenous ochronosis. 
 
ARB was detected in two creams (one containing CP) and the mean concentrations 
found were 0.063% in SLC49 and 0.003% (m/m) in SLC59.  Studies have demonstrated 




PO was found in four creams with levels of 0.092%, 0.261%, and 0.0025% (m/m) for 
SLC51, SLC57 and SLC60, respectively.  PO was not quantified in the fourth cream 
sample (SLC58) because of the presence of KA. 
 
KA was also detected in two samples SLC56 and SLC58.  Due to its tailing factor, op-
timised chromatographic conditions failed to separate KA from other compounds.  KA 
presented a serious peak tailing which could interfere and produce bias in the quantita-
tion of other compounds.  Consequently, levels of KA were calculated neither in SLC56 
nor in SLC58.   
 
Steroid compounds were observed in two creams: one cream (SLC59) contained 
0.055% of CP and another cream (SLC52) had 0.0031% of HCV.  Topical steroids are 
effective anti-inflammatory preparations used to control eczema and many other skin 
conditions.
87
  Concentrations of CP and HCV detected in the studied creams are con-
sistent with the maximum medically used concentration (0.05%) of most steroids 
agents.
89, 143
  Clobetasol propionate and hydrocortisone are associated with local side-
effects including straie, redness, scaling and epidermal thinning as well as systemic 
side-effects such as dysfunction of the hypothalamus, Cushing’s syndrome and neuropa-
thy.
91, 152, 153



















SLC18  - - - 
SLC19 - - - 
SLC20 NA 18.554 ± 1.95 0.232 
SLC21 NA 18.723 ± 0.713 1.170 
SLC26 - - - 
SLC31 NA 1.474 ± 0.10 0.035 
SLC33 - - - 
SLC49 ARB 2.524 ± 0.26 0.063 
SLC50 -  - 
SLC51 
BQ 7.320 ± 0.82 0.036 
PO 18.40 ± 0.78 0.920 
SLC52 HCV 1.226 ± 0.79 0.003 
SLC53 - - - 
SLC54 
HQ 15.044 ± 0.58 0.940 
BQ 1.560 ± 0.14 0.008 
SLC55 - - - 
SLC56 KA* - - 
SLC57 PO 10.445 ± 0.79 0.261 
SLC58 
PO* - - 
KA* - - 
SLC59 
ARB 1.204 ± 0.16 0.003 
CP 4.418 ± 0.31 0.055 
SLC60 PO 1.023 ± 0.13 0.0025 
* Not quantified in the product 






SUMMARY AND CONCLUSIONS 
 
This research has investigated some of the most popular skin-lightening creams, 
commercially available on South African markets.  The sample products were 
manufactured in different countries: about 40% were from in South Africa, about 18% 
from India, about 10% from Pakistan, about 10% from Europe and USA, and about 6% 
from East Africa. For about 15% of the sample products, the countries of manufacture 
were not known. 
 
The aim of the study was to identify and quantify active ingredients and heavy metals 
that might be contained in commonly used skin-lightening creams in order to provide 
information that can guide everyone in choosing safe cosmetic skin products.  
 
The analysis of the skin-lightening creams was carried out in two parts.  The first part 
involved the determination of heavy metals by using ICP-OES and/or CV-AAS.  The 
second part concerned the determination of organic active ingredients by means HPLC. 
 
Determination of heavy metals by means of ICP-OES and/or CV-AAS 
 
All screened skin-lightening creams were found to be free from cobalt, cadmium, 
arsenic, and nickel.  This is good news to the users of these products because they will 




Iron and copper have been detected, but at low levels (at about 0.5 mg g
-1
), except for 
one case in which iron exceeds 20 mg g
-1
.  The presence of iron and copper at low 
levels is not of concern to the users since these are essential elements recommended for 
the human diet at low concentrations.
158
  This, however, does not imply that we 
recommend the inclusion of iron or copper in cosmetic creams as it might boost, 





Metals such as lead and chromium have been found at levels not higher than 16 μg g
-1
, 
in less than ten creams.  Lead and chromium are used as colour additives in cosmetics.  
Exposure to lead can result in high blood pressure, kidney damage, infertility, and 
miscarriages.
37
  Chromium causes allergy contact dermatitis, in particular, Chromium 
(VI) is a known carcinogen.
102
  One of the three sample creams that was found to 
contain mercury had a relatively high concentration of 51.2 μg g
-1
.  This result is a cause 
for concern because the inclusion of any form of mercury, in skin-lighteners is currently 
forbidden because of its toxicity. 
 
Determination of organic active ingredients by means of HPLC 
 
The following active ingredients were detected in the 19 creams that were analysed by 
means of HPLC: hydroquinone, niacinamide also called Vit B3, arbutin, benzoquinone, 
phenol, clobetasol propionate, and hydrocortisone valerate.  Quantitative results indicate 
that about 63% of the analysed creams had at least one or two of the above-mentioned 
active ingredients. 
 
Hydroquinone was found in one cream only with a concentration of 0.94% (m/m) that is 
below the WHO limit of 2% (m/m) but its toxicity may not be ignored. Benzoquinone 
was detected in two creams of which one contains hydroquinone and the other one 
contained phenol.  Phenol was found in four creams.  Arbutin was detected in two 
creams and niacinamide in three creams.  To the best of our knowledge, there is no limit 
on the concentration of arbutin and niacinamide in cosmetic products.  Thus, 
concentrations obtained for these ingredients cannot be judged as high or low.  The 
determined mean concentration ranges were: 0.0025-0.261%, 0.004-0.036%, 0.003-
0.0063%, and 0.0035-1.17% for phenol, benzoquinone, arbutin and niacinamide, 
respectively.  Steroids, namely clobetasol and hydrocortisone, were detected in two 
creams and were found to be compliant with therapeutic levels (≤ 0.05% w/w) for 
ointment creams.  
 
Levels of the active organic ingredients detected in skin-lightening creams are low and 




however, the user who applies any of these creams may experience some effects such 
as, skin discoloration, redness, acnes and systemic diseases particularly after repeated 
and long-term exposure. 
 
In view of the findings of this study (Table 4.1) and the toxicological effects associated 
with lead (Pb), chromium (Cr), mercury (Hg), hydroquinone (HQ), clobetasol 
propionate (CP), and hydrocortisone valerate (HCV), efforts should be made in all 
countries in order to abolish inclusion of these agents or any toxic ingredient in 
commercial skin-lightening creams.  Efforts should also be made to educate the users 
and the general public on the possible dangers associated with the skin-lightening 
practices. 
 
We have collected and investigated a few samples of creams that are sold in South 
Africa, but there are hundreds of brands that are available from around the world.  It is 
worth noting that although many of the most important skin-lightening creams have 
now been reformulated with new ingredients, they may still contain harmful ingredients 
that can induce long-term side effects including permanent skin damage.  Therefore, we 
recommend that before buying any skin-care products or any other cosmetic products, 
the user must double check the labelling, and fully understand whether the product is 
really safe.  People are usually advised not to use skin-lightening creams.  For skin 
conditions that do require such treatment, should only be used under supervision of a 
medical practitioner. 
 
A future study can determine the concentrations of parabens, such as methyl, ethyl, 
propyl and butyl-paraben, used as preservatives in skin-lightening products.  Methyl 
paraben was present in most of the skin-lightening creams tested in this study.  
Similarly, a previous study found high concentrations of parabens in different cosmetic 
creams.
163
  This shows the prevalence of parabens in cosmetics.  Concerns over the 








Table 4.1: Detection overview of metal and organic active ingredient contained the 
investigated skin-lightening creams. 
Sample code Metal 
Organic active 
ingredient 
SLC2 Cr, Cu, Fe, Pb ˗ 
SLC4 Cr, Cu, Fe, Pb ˗ 
SLC11 Cu, Fe, Hg ˗ 
SLC17 Cu, Fe, Pb - 
SLC20 Cu, Fe NA 
SLC21 Cu, Fe NA 
SLC27 Cr, Cu, Fe ˗ 
SLC31 Cu, Fe NA 
SLC39 Cr, Cu, Fe, Hg ˗ 
SLC43 Cu, Fe, Hg ˗ 
SLC45 Cu, Fe, Hg, Zn ˗ 
SLC46 Cr, Cu, Fe ˗ 
SLC47 Cr, Cu, Fe ˗ 
SLC49 Cu, Fe, ARB 
SLC51 ˗ BQ, PO 
SLC52 ˗ HCV 
SLC54 ˗ HQ, BQ 
SLC56 ˗ CP 
SLC57 ˗ PO 
SLC58  KA 
SLC59 ˗ KA, PO 
SLC60 ˗ ARB 
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The different chemicals, including analytical grade reagents and other consumable ma-
terials, used during the study are listed below. 
 
A1 Chemicals used for the determination of active skin-lightening agents by HPLC 
 
Chemical Supplier 
Acetonitrile (HiperSolvTM, HPLC grade) BDH Chemicals, Ltd 
Methanol (HPLC grade) Merck 
Millipore water Elix 5 UV Millipore  
Hydroquinone (99.09%) Fluka 
Phenol (99.5%) Fluka 
Benzoquinone (99.5%) Fluka 
Resorcinol (99%) 
Niacinamide (99.9%) 
Kojic acid (98%) 
Arbutin (96%) 
Clobetasol dipropionate (98%) 
Hydrocortisone valerate (98.7%) 


















Tin chloride dihydrate ( SnCl₂.2H₂O) Associated Chemical Enterprises 
Mercury chloride (HgCl₂) BDH Laboratory Reagents 
Analytical grade, Cadmium 1000 ppm  Fluka Chemicals 
Analytical grade, Chromium  1000 ppm Fluka Chemicals 
Analytical grade, Iron (Fe) 1000 ppm Fluka Chemicals 
Analytical grade, Lead (Pb) 1000 ppm Fluka Chemicals 
Analytical grade, Zinc (Zn) 1000 ppm Fluka Chemicals 
Analytical grade, nitric acid (≥ 69%)  Riedel-de Haёn  







INSTRUMENTATION AND EQUIPMENT 
 




Perkin Elmer Lambda 25 UV/VIS dual beam spectrophotometer 
 
Shimadzu Prominence HPLC equipped with: 
DGU-20A3 Prominence Degasser, 
A & B LC-20AD/UFLC XR Prominence Liquid Chromatograph,  
SIL-20A/UFLC-XR Prominence Autosampler,  
SPD-M20A Prominence Diode Array Detector,   
CTO-20A Prominence Column Oven and 
CBM-20A/UFLC Prominence Communication Bus Module 
 
Perkin-Elmer optima 5300 DV ICP-OES  
 




CEM Mars 6 Microwave digester with a turntable containing 12 reaction vessels (XP-
1500) 
Phenomenex HPLC column; Luna RP-C18 (250 mm × 4.6 mm, 5.0 µm)  
Brownlee HPLC column; C18 (100 mm × 4.6 mm, 5.0 μm) 
Ultrasonic bath (Ultra Manufacturing Company)  
Millipore Milli-Q
 
water purification system 
Millipore Millex hydrophilic PFTE 0.45 μm syringe filters 
Millipore Durapore
®








This section presents in tables, the calibration data of all heavy metals and organic ac-
tive ingredients studied in this investigation. 
 
C1  Calibration data for heavy metals 
 






0.02 0.04 0.06 0.08 0.1 
1 6108.4 13210.6 20197.8 25676.2 32709.2 
2 6718.8 12917.5 19376.3 26835 32293.8 
3 6418.1 13076.2 19464.2 27032.3 33041.2 
Mean 6415.1 13068.1 19679.4 26514.5 32681.4 
Std Dev 305.1862 146.7165 451.1 732.6717 374.4998 
RSD/% 4.757327 1.122708 2.292089 2.763286 1.145912 









0.02 0.04 0.06 0.08 0.1 
1 1669.8 3279.9 5294.1 6645.2 8651.1 
2 1589.9 2996.6 4951.7 6428.9 8199.1 
3 1653.4 3351 5071.5 6762.1 8452.5 
Mean 1637.7 3209.2 5105.8 6612.1 8434.2 
Std Dev 42.20036 187.4969 173.753 169.0308 226.553 









0.02 0.04 0.06 0.08 0.1 
1 159.1 284.3 495.9 539.3 676.1 
2 157.5596 315.1192 472.6788 609.2384 717.8 
3 152.8 278.7 470.9 590.5 773.8 
Mean 156.4865 292.7064 479.8263 579.6795 722.5667 
Std Dev 3.28422 19.61097 13.94865 36.20301 49.02411 
RSD/% 2.098724 6.699878 2.90702 6.24535 6.784718 
 





0.01 0.02 0.04 0.06 0.08 0.1 
1 581.2 1150.2 2253.7 3442.5 4567.3 5723.7 
2 574.8 1171.9 2396.9 3538.2 4516.8 5697.5 
3 569.1 1138.1 2240.6 3601.2 4324.5 5591.1 
Mean 574.6 1153.4 2297.07 3527.3 4469.53 5670.77 
Std Dev 6.05 17.13 86.76 79.91 128.12 70.23 
RSD/% 1.05 1.48 3.77 2.26 2.86 1.24 
 
 Table C1-5: Calibration data for the determination of mercury (Hg). 
weight /ng 100 200 300 400 500 600 
1 0.088 0.166 0.225 0.326 0.389 0.503 
2 0.081 0.162 0.25 0.322 0.401 0.483 
3 0.101 0.157 0.233 0.33 0.418 0.477 
Mean 0.09 0.162 0.236 0.326 0.403 0.488 
Std Dev 0.010 0.005 0.013 0.004 0.015 0.014 
RSD/% 11.276 2.789 5.410 1.223 3.619 2.792 
 





0.1 0.2 0.3 0.4 0.5 
1 4178.1 8091.4 12414.7 15989.7 20902.3 
2 4300.6 8309.1 12401 16732.8 20813.6 
3 3995.9 7998.8 11981.3 15992.2 20502.7 
Mean 4158.2 8133.1 12265.6 16238.2 20739.5 
Std Dev 153.3 159.3 246.3 428.3 209.8 





C2 Calibration data for the organic active skin-lightening ingredients 
 





1.25 2.5 5 10 15 20 25 
1 15001 30650 60855 120198 180841 240577 300200 
15022 30052 60120 120004 180149 240013 300893 
15045 30124 60585 120344 180115 240821 301081 
2 15178 30681 61162 121839 180802 241914 300580 
15105 30675 60028 121631 190031 241754 300730 
14999 30020 60034 126562 190048 241358 304471 
3 14921 29996 60023 120327 180675 241039 300469 
14998 29945 59992 120398 180214 240112 301218 
14974 30015 60100 120045 180009 240333 300543 
Mean 15027 30239.8 54290.4 121260.9 182542.7 240880.1 301131.7 
Std Dev 75.5 325.2 435.4 2098.2 4261.5 691.3 1291.2 
RSD/% 0.5 1.1 0.8 1.7 2.3 0.3 0.4 
 
 





1.25 2.5 5 10 15 20 25 
1 13562 26515 53456 107770 160554 211889 261445 
13655 26276 53517 102871 158956 212409 271878 
13271 26125 52738 106428 160903 211604 269796 
2 12953 25993 51814 106812 155722 209089 259398 
12982 26063 51896 103564 155206 210125 257121 
12887 25834 51844 103769 155812 207329 261947 
3 13399 26059 52976 106052 159053 210805 263244 
13465 26404 53061 106002 158189 211620 268885 
12955 26992 53083 106744 158013 210527 265006 
Mean 13236.5 26251.2 52709.4 105556.9 158045.3 210599.7 264302.2 
Std Dev 297.4 348.4 685.3 1712.7 2084.9 1590.5 4994.0 













0.625 1.25 2.5 5 10 15 20 
1 42987 82400 175916 355338 724648 1052193 1420534 
42229 82676 174050 353523 722852 1050472 1428770 
40748 83464 175384 351397 720103 1040883 1430014 
2 42424 83765 172257 343906 700285 1042453 1424335 
42542 83841 173338 343814 700786 1052378 1425073 
41809 81716 172153 342401 698026 1043124 1427903 
3 43187 86634 178509 321881 691287 1056251 1427907 
43407 86744 169460 327628 697284 1055021 1400156 
43623 86614 179876 317161 697910 1047843 1400922 
Mean 42550.7 84206 174549.2 339672.1 705909 1048958 1420624 
Std Dev 894.3 1962.6 3264.0 14078.4 12805.7 5670.1 11732.6 
RSD/% 2.1 2.3 1.9 4.1 1.8 0.5 0.8 
 
 





0.625 1.25 2.5 5 10 15 20 
1 2014 3879 7743 15244 30617 46020 61532 
2248 3852 7710 15245 30541 45727 61381 
2052 3919 7724 15488 30982 45983 60833 
2 2092 3669 8193 15988 31429 47007 61143 
2069 3700 8099 16974 31307 47090 60833 
2017 3783 8615 16102 31757 46252 61731 
3 2100 3712 7596 16192 30591 47772 61362 
2093 3795 7618 16665 31093 47103 61036 
2008 3755 7689 16915 30965 47395 61685 
Mean 2077 3784.9 7887.4 16090.3 31031.3 46705.4 55155.6 
Std Dev 73.5 85.4 343.4 671.4 414.9 721.5 340.2 















0.625 1.25 2.5 5 10 20 
1 8252 16676 32648 65994 131618 277728 
8338 16327 32465 65668 136205 274528 
8148 16676 32522 66468 136534 272988 
2 8843 17666 35073 70747 141494 287728 
8804 17680 35338 70007 144564 284528 
8888 17657 35754 70684 147429 282988 
3 8599 17984 35569 70106 142279 284658 
8848 17401 35488 71139 149052 286790 
8792 17849 36127 71531 145227 282455 
Mean 8612 17324 34554 69149 141600 281599 
Std Dev 290 603 1534 2384 5770 5294 
RSD/% 3 3 4 3 4 2 
 
 





0.391 0.781 1.562 3.125 6.25 12.5 25 
1 8218 17654 37432 69540 129763 268839 611642 
9235 19475 36950 73901 144802 295604 591208 
8064 17990 36032 71575 149315 306303 602606 
2 9319 18616 37232 74464 148928 297857 595715 
9308 18257 37051 74103 144061 299785 592882 
9128 18025 37515 74610 144911 295778 588243 
3 9203 18517 37034 71068 138137 276275 590886 
9258 19832 36539 71792 138522 270443 579255 
9213 19026 36805 72676 139937 275307 574081 
Mean 8994 18599 36954 72637 142042 287355 591835 
Std Dev 488 723 458 1763 6155 14403 11248 















0.391 1.562 3.125 6.25 12.5 25 
1 7952 31455 69540 157668 307658 642696 
8047 31923 73901 156549 305932 642673 
8319 31601 71575 156814 305635 647904 
2 8392 30869 74464 138944 299651 613419 
8312 30253 74103 140016 279473 617517 
8341 30856 74610 139952 289689 610045 
3 8309 32477 71068 141983 301341 636034 
8701 33505 71792 149252 309913 628027 
8511 35958 72676 146564 305860 630125 
Mean 8320 32100 72637 147527 300572 629827 
Std Dev 223 1738 1763 7847 9905 13745 







CALIBRATION GRAPHS AND RESIDUAL 
PLOTS 
This section presents the calibration graphs and the residual plots used for the determi-
nation of heavy metals and active organic ingredients in skin-lightening creams ana-
lysed in this investigation.  For ICP-OES, instrument conditions were: generator power, 
1000 W; plasma gas flow rate, 12 L min
-1
; nebulizer pressure, 3 bars and sample flow 
rate, 1 mL min
-1
. 
Figure D1: ICP-OES calibration graph for the determination of chromium.  The analyti-
cal wavelength was 267.716 nm. 
Figure D2: Residual plot for the calibration graph of chromium. 
y = 8.363 × 104 x 


















































Figure D3: ICP-OES calibration graph for the determination of copper.  The analytical 
wavelength was 324.752 nm. 
 

































y = 3.282 ×105 x 






















Figure D5: ICP-OES calibration graph for the determination of lead.  The analytical 
wavelength was 220.353 nm. 
 



































y = 7.375 × 103 x 





















Figure D7: ICP-OES calibration graph for the determination of iron.  The analytical 
wavelength was 259.939 nm. 
 
 
Figure D8: Residual plot for the calibration graph of iron. 
 
y = 8.213 × 104 x 





















































Figure D9: CV-AAS calibration graph for the determination of mercury.  The analytical 
wavelength was 253.652 nm. 
 
 
Figure D10: Residual plot the calibration graph of mercury. 
y = 0.0008x 








































Figure D11: ICP-OES calibration graph for the determination of zinc.  The analytical 
wavelength was 213.857 nm. 
 
 
Figure D12: Residual plot for the calibration graph of zinc. 
 
y = 4.107 × 104 x 




















































Figure D13: HPLC calibration graph for the determination of HQ.  The detection wave-
length was 289 nm. 
 
 
Figure D14: Residual plot for the calibration graph of HQ. 
 
y = 1.2072 × 104 x 













































Figure D15: HPLC calibration graph for the determination of PO.  The detection wave-
length was 270 nm. 
 
Figure D16: Residual plot for the calibration graph of PO. 
 
 
y = 1.055 × 104 x 















































Figure D17: HPLC calibration graph for the determination of BQ.  The detection wave-
length was 240 nm. 
 
 
Figure D18: Residual plot for the calibration graph of BQ. 
y = 7.053 × 104 x 















































Figure D19: HPLC calibration graph for the determination of ARB.  The detection 
wavelength was 289 nm. 
 
Figure D20: Residual plot for the calibration graph of ARB. 
 
y = 3.090 × 103 x 












































Figure D21: HPLC calibration graph for the determination of NA.  The detection 
wavelength was 270 nm. 
 
Figure D22: Residual plot for the calibration graph of NA. 
 
y = 1.408 × 104 x 



















































Figure D23: HPLC calibration graph for the determination of CP.  The detection 
wavelength was 240 nm. 
 
Figure D24: Residual plot for the calibration graph of CP. 
 
 
y = 2.350 × 104x 











































Figure D25: HPLC calibration graph for the determination of HCV.  The detection 
wavelength was 240 nm. 
 
 
Figure D26: Residual plot for the calibration graph of HC
y = 2.484 × 104 x 


















































I. Chromatograms show the separation of a standard mixture of skin-lightening ac-
tive ingredients.  The chromatographic conditions used were: Brownlee C18 
column mobile phase, MeOH-H2O 55:45% (v/v), injection volume: 10 μL, flow 
rate 0.8 mL min
-1
, and detection wavelength: 240, 270, or 289 nm.  
 
 
Figure E1: Typical chromatogram for the separation of a standard mixture of skin-
lightening active ingredients at 240 nm.  The order of elution is HQ, BQ and HCV and 





Figure E2: Typical chromatogram for the separation of a standard mixture of skin-
lightening active ingredients at 270 nm.  The order of elution is NA, BQ, PO, HCV and 
CP.  The retention time is at 1.408, 1.71733, 2.464, 5.0133 and 8.224 minutes, respec-
tively. 
 
Figure E3: Typical chromatogram for the separation of a standard mixture of skin-
lightening active ingredients at 289 nm.  The order of elution is ARB, HQ and HCV.  





II. Chromatograms of skin-lightening cream samples (SLC).  The chromatographic 
conditions used were: Brownlee C18 column mobile phase, MeOH-H2O 55:45% 
(v/v), injection volume - 10 μL, flow rate 0.8 mL min
-1
, and detection wave-
length – 240, 270, or 289 nm.  
 
 
Figure E5: chromatogram of SLC20.  The active ingredient is NA.  The retention time is 






Figure E6: chromatogram of SLC21.  The active ingredient is NA.  The retention time is 
at 1.4298 minutes.  The detection wavelength is 270 nm. 
Figure E7: chromatogram of SLC31.  The active ingredient is NA.  The retention time is 





Figure E8: chromatogram of SLC49.  The active ingredient is ARB.  The retention time 
is at 1.30133 minutes.  The detection wavelength is 289 nm. 
 
Figure E9: chromatogram of SLC51.  The active ingredient is BQ.  The retention time is 





Figure E10: chromatogram of SLC51.  The active ingredient is PO.  The retention time 
is at 2.45333 minutes.  The detection wavelength is 270 nm. 
 
Figure E11: chromatogram of SLC52.  The active ingredient is HCV.  The retention 




Figure E12: chromatogram of SLC54.  The active ingredient is BQ.  The retention time 
is at 1.73887 minutes.  The detection wavelength is 240 nm. 
Figure E13: chromatogram of SLC54.  The active ingredient is HQ.  The retention time 




Figure E14: chromatogram of SLC56.  The active ingredient is KA.  The retention time 
is at 1.472 minutes.  The detection wavelength is 270 nm. 
Figure E15: chromatogram of SLC58.  The order of elution is KA and PO.  The reten-
tion time is at 1.4613, and 2.4533 minutes, respectively, for active ingredient.  The de-




Figure E16: chromatogram of SLC60.  The active ingredient is PO.  The retention time 
is at 2.464 minutes.  The detection wavelength is 270 nm. 
 
Figure E17: chromatogram of KA standard solution.  The retention time is at 1.46133 






RAW DATA FOR SKIN-LIGHTENING 
CREAMS 
 
The following tables list the peak areas obtained for the organic active ingredients in the 
different skin-lightening creams analysed by HPLC. 
 
SLC20 SLC21 SLC31 SLC49 SLC51 SLC52 
NA NA NA ARB BQ PO HCV 
291917 252803 20697 7786 507816 194120 31801 
253658 251672 18723 7753 516932 197812 31583 
262144 249230 19295 7896 486210 174830 31023 
222281 266741 22653 8532 459665 200330 28898 
246583 270186 20765 8910 580252 202520 31156 
228183 262713 23197 8702 426872 199465 33690 
301256 273017 20136 6846 496321 192812 26983 
286532 270033 21362 6986 572568 189657 29214 
258670 276125 19956 6783 600125 195587 29683 
Df  1:5 Df  1:25   Df  1:2 Df  1:20  
Df – dilution factor 
SLC54 SLC57 SLC59 SLC60 
HQ BQ PO ARB CP PO 
191297 112273 111652 3908 102369 10048 
182551 109312 118596 4136 93982 10320 
175456 110282 97864 4011 98588 13120 
187173 102079 120556 4325 110923 10220 
185042 111402 116593 3918 115551 9264 
188129 133678 114218 3900 111042 9463 
172492 100890 100982 2896 105663 10358 
171985 101049 101062 3015 98679 11638 
180413 109284 110208 3392 97668  12712 
Df  1:25 Df  1:2 Df  1:10  Df  1:5  
 
